CA2221162C - Photocrosslinked polymers and prepolymers thereof - Google Patents
Photocrosslinked polymers and prepolymers thereof Download PDFInfo
- Publication number
- CA2221162C CA2221162C CA002221162A CA2221162A CA2221162C CA 2221162 C CA2221162 C CA 2221162C CA 002221162 A CA002221162 A CA 002221162A CA 2221162 A CA2221162 A CA 2221162A CA 2221162 C CA2221162 C CA 2221162C
- Authority
- CA
- Canada
- Prior art keywords
- carbon atoms
- prepolymer
- alkylene
- solution
- polyvinyl alcohol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C35/00—Heating, cooling or curing, e.g. crosslinking or vulcanising; Apparatus therefor
- B29C35/02—Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould
- B29C35/08—Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould by wave energy or particle radiation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29D—PRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE
- B29D11/00—Producing optical elements, e.g. lenses or prisms
- B29D11/00009—Production of simple or compound lenses
- B29D11/00432—Auxiliary operations, e.g. machines for filling the moulds
- B29D11/00442—Curing the lens material
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C31/00—Handling, e.g. feeding of the material to be shaped, storage of plastics material before moulding; Automation, i.e. automated handling lines in plastics processing plants, e.g. using manipulators or robots
- B29C31/04—Feeding of the material to be moulded, e.g. into a mould cavity
- B29C31/041—Feeding of the material to be moulded, e.g. into a mould cavity using filling or dispensing heads placed in closed moulds or in contact with mould walls
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C35/00—Heating, cooling or curing, e.g. crosslinking or vulcanising; Apparatus therefor
- B29C35/02—Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould
- B29C35/08—Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould by wave energy or particle radiation
- B29C35/0888—Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould by wave energy or particle radiation using transparant moulds
- B29C35/0894—Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould by wave energy or particle radiation using transparant moulds provided with masks or diaphragms
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C37/00—Component parts, details, accessories or auxiliary operations, not covered by group B29C33/00 or B29C35/00
- B29C37/0003—Discharging moulded articles from the mould
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C37/00—Component parts, details, accessories or auxiliary operations, not covered by group B29C33/00 or B29C35/00
- B29C37/0003—Discharging moulded articles from the mould
- B29C37/0007—Discharging moulded articles from the mould using means operable from outside the mould for moving between mould parts, e.g. robots
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C37/00—Component parts, details, accessories or auxiliary operations, not covered by group B29C33/00 or B29C35/00
- B29C37/005—Compensating volume or shape change during moulding, in general
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C39/00—Shaping by casting, i.e. introducing the moulding material into a mould or between confining surfaces without significant moulding pressure; Apparatus therefor
- B29C39/22—Component parts, details or accessories; Auxiliary operations
- B29C39/24—Feeding the material into the mould
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C39/00—Shaping by casting, i.e. introducing the moulding material into a mould or between confining surfaces without significant moulding pressure; Apparatus therefor
- B29C39/22—Component parts, details or accessories; Auxiliary operations
- B29C39/36—Removing moulded articles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C39/00—Shaping by casting, i.e. introducing the moulding material into a mould or between confining surfaces without significant moulding pressure; Apparatus therefor
- B29C39/22—Component parts, details or accessories; Auxiliary operations
- B29C39/42—Casting under special conditions, e.g. vacuum
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29D—PRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE
- B29D11/00—Producing optical elements, e.g. lenses or prisms
- B29D11/00009—Production of simple or compound lenses
- B29D11/00038—Production of contact lenses
- B29D11/00057—Production of contact lenses characterised by the shape or surface condition of the edge, e.g. flashless, burrless, smooth
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29D—PRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE
- B29D11/00—Producing optical elements, e.g. lenses or prisms
- B29D11/00009—Production of simple or compound lenses
- B29D11/00038—Production of contact lenses
- B29D11/00125—Auxiliary operations, e.g. removing oxygen from the mould, conveying moulds from a storage to the production line in an inert atmosphere
- B29D11/00134—Curing of the contact lens material
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B1/00—Optical elements characterised by the material of which they are made; Optical coatings for optical elements
- G02B1/04—Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
- G02B1/041—Lenses
- G02B1/043—Contact lenses
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C35/00—Heating, cooling or curing, e.g. crosslinking or vulcanising; Apparatus therefor
- B29C35/02—Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould
- B29C35/08—Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould by wave energy or particle radiation
- B29C35/0805—Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould by wave energy or particle radiation using electromagnetic radiation
- B29C2035/0827—Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould by wave energy or particle radiation using electromagnetic radiation using UV radiation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C33/00—Moulds or cores; Details thereof or accessories therefor
- B29C33/30—Mounting, exchanging or centering
- B29C33/303—Mounting, exchanging or centering centering mould parts or halves, e.g. during mounting
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
- B29L2011/00—Optical elements, e.g. lenses, prisms
- B29L2011/0016—Lenses
- B29L2011/0041—Contact lenses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S525/00—Synthetic resins or natural rubbers -- part of the class 520 series
- Y10S525/937—Utility as body contact e.g. implant, contact lens or I.U.D.
Abstract
The invention relates to a novel process for the manufacture of mouldings, especially contact lenses, in which a soluble prepolymer comprising crosslinkable groups iscross-linked in solution, and also to mouldings, especially contact lenses, obtainable in accordance with that process. The present invention relates also to novel prepolymers that can be used in the process according to the invention, especially derivatives of a polyvinyl alcohol having a molecular weight of at least about 2000 that, based on the number of hydroxy groups of the polyvinyl alcohol, comprise from approximately 0.5 to approximately 80 % of units of formula I
(see fig. I) wherein R is lower alkylene having up to 8 carbon atoms, R1 is hydrogen or lower alkyl and R2 is an olefinically unsaturated, electron-attracting, copolymerisable radical preferably having up to 25 carbon atoms, to crosslinked polymers, either homo- or co-polymers of those novel prepolymers, to processes for the preparation of the novel prepolymers and the homo- and co-polymers obtainable therefrom, to mouldings made from the said homo- or co-polymers, especially contact lenses made from those homo- or co-polymers, and to processes for the manufacture of contact lenses using the said homo- or co-polymers.
(see fig. I) wherein R is lower alkylene having up to 8 carbon atoms, R1 is hydrogen or lower alkyl and R2 is an olefinically unsaturated, electron-attracting, copolymerisable radical preferably having up to 25 carbon atoms, to crosslinked polymers, either homo- or co-polymers of those novel prepolymers, to processes for the preparation of the novel prepolymers and the homo- and co-polymers obtainable therefrom, to mouldings made from the said homo- or co-polymers, especially contact lenses made from those homo- or co-polymers, and to processes for the manufacture of contact lenses using the said homo- or co-polymers.
Description
This application is a divisional application of application No. 2,129,461 filed on August 4th, 1994.
The invention of the parent application relates to a novel process for the manufacture of mouldings, especially contact lenses, in which a soluble prepolymer comprising crosslinkable groups is crosslinked in solution, and also to mouldings, especially contact lenses, obtainable in accordance with that process.
The invention of the parent application provides a process for the manufacture of a moulding, which comprises the following steps:
a) preparing a substantially aqueous solution of a water-soluble prepolymer that comprises crosslinkable groups, b) introducing the solution obtained into a mould, c) triggering of crosslinking, and d) opening the mould so that the moulding can be removed.
The invention of the divisional application relates to novel prepolymers that can be used in the process according to the invention, especially to those based on polyvinyl alcohol that comprise cyclic acetal groups and crosslinkable groups, to crosslinked polymers, either homo- or co-polymers of those novel prepolymers, to processes for the preparation of the novel prepolymers and the homo- and co-polymers obtain-able therefrom, to mouldings made from the said homo- or co-polymers, especially contact lenses made from those homo- or co-polymers, and to processes for the manufacture of contact lenses using the said homo- or co-polymers.
The invention of the parent application relates to a novel process for the manufacture of mouldings, especially contact lenses, in which a soluble prepolymer comprising crosslinkable groups is crosslinked in solution, and also to mouldings, especially contact lenses, obtainable in accordance with that process.
The invention of the parent application provides a process for the manufacture of a moulding, which comprises the following steps:
a) preparing a substantially aqueous solution of a water-soluble prepolymer that comprises crosslinkable groups, b) introducing the solution obtained into a mould, c) triggering of crosslinking, and d) opening the mould so that the moulding can be removed.
The invention of the divisional application relates to novel prepolymers that can be used in the process according to the invention, especially to those based on polyvinyl alcohol that comprise cyclic acetal groups and crosslinkable groups, to crosslinked polymers, either homo- or co-polymers of those novel prepolymers, to processes for the preparation of the novel prepolymers and the homo- and co-polymers obtain-able therefrom, to mouldings made from the said homo- or co-polymers, especially contact lenses made from those homo- or co-polymers, and to processes for the manufacture of contact lenses using the said homo- or co-polymers.
Contact lenses based on polyvinyl alcohol are already known. For example, contact lenses comprising polyvinyl alcohol that has (meth)acryloyl groups bonded by way of urethane groups are disclosed, for example, in EP 216 074.
Contact lenses made from polyvinyl alcohol crosslinked with polyepoxides are described in EP 189 375.
Also already known are some special acetals that comprise crosslinkable groups. Reference is made in that connection, for example, to EP 201 693, EP 215 245 and EP 211 432. EP 201 693 describes, inter alia, acetals of unbranched aldehydes having from 2 to 11 carbon atoms that carry a terminal amino group that has been substituted by a C3-C24-olefinically unsaturated organic radical. That organic radical has a functionality that removes electrons from the nitrogen atom, and also the olefinically unsaturated functionality is polymerisable. Also claimed in EP 201 693 are reaction products of the above-characterised acetals with a 1,2-diol, a 1,3-diol, a polyvinyl alcohol or a cellulose.
Products of that kind are not, however, expressly described.
Inasmuch as one of the acetals according to EP 201 693 is mentioned at all in connection with, for example, polyvinyl alcohol, as is the case, inter alia, in Example 17 of that Patent Application, then the acetal polymerisable by way of its olefinic group is first copolymerised, for example, with vinyl acetate. The copolymer so obtained is then reacted with polyvinyl alcohol, and an emulsion with a pH of 5.43 and a viscosity of 11640 cps which contains 37~ solids is obtained.
In contrast, the invention of the divisional application is directed, inter alia, to prepolymers that comprise a 1,3-diol basis structure in which a certain percentage of the 1,3-diol units have been modified to a 1,3-dioxane having in the 2-position a radical that is polymerisable but not polymerised. The polymerisable radical is especially an aminoalkyl radical having a polymerisable group bonded to the nitrogen atom. The present invention relates also to crosslinked homo- or co-polymers of the said prepolymers, to processes for the preparation of the novel prepolymers, to the homo- and co-polymers obtainable therefrom, to mouldings made from the said homo- or co-polymers, especially to contact lenses made from those homo-or co-polymers, and to processes for the manufacture of contact lenses using the said homo- or co-polymers.
The prepolymer according to the invention of the divisional application is preferably a derivative of a polyvinyl alcohol having a molecular weight of at least about 2000 that, based on the number of hydroxy groups of the polyvinyl alcohol, comprises from approximately 0.5 to approximately 80~ of units of formula I
3a CH
O O
\CH
/R
R-N
wherein R is lower alkylene having up to 8 carbon atoms, R1 is hydrogen or lower alkyl and R2 is an olefinically unsaturated, electron-attracting, copolymerisable radical preferably having up to 25 carbon atoms.
R2 is, for example, an olefinically unsaturated acyl radical of formula R3-CO-, in which R3. is an olefinically unsaturated copolymerisable radical having from 2 to 24 carbon atoms, preferably from 2 to 8 carbon atoms, especially preferably from 2 to 4 carbon atoms. In another embodiment the radical R2 is a radical of formula II
-CO-NH(R4-NH-CO-O)q-R5-O-CO-R3 (II) wherein q is zero or one and R4 and R5 are each independently lower alkylene having from 2 to 8 carbon atoms, arylene having from 6 to 12 carbon atoms, a saturated divalent cycloaliphatic group having from 6 to 10 carbon atoms, arylenealkylene or alkylenearylene having from 7 3b to 14 carbon atoms or arylenealkylenearylene having from 13 to 16 carbon atoms, and R3 is as defined above.
The prepolymer according to the invention of the divisional application is therefore especially a derivative of a polyvinyl alcohol having a molecular weight of at least about 2000 that, based on the number of hydroxy groups of the polyvinyl alcohol, comprises from approximately 0.5 to approximately 80~ of units of formula III
/CH2\ ~CH2~
CH CH
cu-~) o~~ o R- N~ [CO-NH-(R a-NH-CO-O) ~-R 5-O]p-CO-R 3 wherein R is lower alkylene, R1 is hydrogen or lower alkyl, p is zero or one, q is zero or one, R3 is an olefinically unsaturated copolymerisable radical having from 2 to 8 carbon atoms and R4 and RS are each independently lower alkylene having from 2 to 8 carbon atoms, arylene having from 6 to 12 carbon atoms, a saturated divalent cycloaliphatic group having from 6 to 10 carbon atoms, arylenealkylene or alkylenearylene having from 7 to 14 carbon atoms or arylenealkylenearylene having from 13 to 16 carbon atoms.
Lower alkylene R preferably has up to 8 carbon atoms and may be straight-chained or branched. Suitable examples include octylene, hexylene, pentylene, butylene, propylene, ethylene, methylene, 2-propylene, 2-butylene and 3-pentylene. Preferably lower alkylene R has up to 6 and especially preferably up to 4 carbon atoms. The meanings methylene and butylene are especially preferred.
Rt is preferably hydrogen or lower alkyl having up to seven, especially up to four, carbon atoms, especially hydrogen.
Lower ~kylene R4 or RS preferably has from 2 to 6 carbon atoms and is especially straight-chained. Suitable examples include propylene, butylene, hexylene, dimethyl-ethylene and, especially preferably, ethylene.
Arylene R4 or RS is preferably phenylene that is unsubstituted or is substituted by lower alkyl or lower alkoxy, especially 1,3-phenylene or 1,4-phenylene or methyl-1,4-phenylene.
A saturated divalent cycloaliphatic group R4 or RS is preferably cyclohexylene or cyclo-hexylene-lower alkylene, for example cyclohexylenemethylene, that is unsubstituted or is substituted by one or more methyl groups, such as, for example, trimethylcyclohexylene-methylene, for example the divalent isophorone radical.
The arylene unit of alkylenearylene or arylenealkylene R4 or RS is preferably phenylene, unsubstituted or substituted by lower alkyl or lower alkoxy, and the alkylene unit thereof is preferably lower alkylene, such as methylene or ethylene, especially methylene. Such radicals R4 or RS are therefore preferably phenylenemethylene or methylenephenylene.
Arylenealkylenearylene R4 or RS is preferably phenylene-lower alkylene-phenylene having up to 4 carbon atoms in the alkylene unit, for example phenyleneethylene-phenylene.
_,.
Contact lenses made from polyvinyl alcohol crosslinked with polyepoxides are described in EP 189 375.
Also already known are some special acetals that comprise crosslinkable groups. Reference is made in that connection, for example, to EP 201 693, EP 215 245 and EP 211 432. EP 201 693 describes, inter alia, acetals of unbranched aldehydes having from 2 to 11 carbon atoms that carry a terminal amino group that has been substituted by a C3-C24-olefinically unsaturated organic radical. That organic radical has a functionality that removes electrons from the nitrogen atom, and also the olefinically unsaturated functionality is polymerisable. Also claimed in EP 201 693 are reaction products of the above-characterised acetals with a 1,2-diol, a 1,3-diol, a polyvinyl alcohol or a cellulose.
Products of that kind are not, however, expressly described.
Inasmuch as one of the acetals according to EP 201 693 is mentioned at all in connection with, for example, polyvinyl alcohol, as is the case, inter alia, in Example 17 of that Patent Application, then the acetal polymerisable by way of its olefinic group is first copolymerised, for example, with vinyl acetate. The copolymer so obtained is then reacted with polyvinyl alcohol, and an emulsion with a pH of 5.43 and a viscosity of 11640 cps which contains 37~ solids is obtained.
In contrast, the invention of the divisional application is directed, inter alia, to prepolymers that comprise a 1,3-diol basis structure in which a certain percentage of the 1,3-diol units have been modified to a 1,3-dioxane having in the 2-position a radical that is polymerisable but not polymerised. The polymerisable radical is especially an aminoalkyl radical having a polymerisable group bonded to the nitrogen atom. The present invention relates also to crosslinked homo- or co-polymers of the said prepolymers, to processes for the preparation of the novel prepolymers, to the homo- and co-polymers obtainable therefrom, to mouldings made from the said homo- or co-polymers, especially to contact lenses made from those homo-or co-polymers, and to processes for the manufacture of contact lenses using the said homo- or co-polymers.
The prepolymer according to the invention of the divisional application is preferably a derivative of a polyvinyl alcohol having a molecular weight of at least about 2000 that, based on the number of hydroxy groups of the polyvinyl alcohol, comprises from approximately 0.5 to approximately 80~ of units of formula I
3a CH
O O
\CH
/R
R-N
wherein R is lower alkylene having up to 8 carbon atoms, R1 is hydrogen or lower alkyl and R2 is an olefinically unsaturated, electron-attracting, copolymerisable radical preferably having up to 25 carbon atoms.
R2 is, for example, an olefinically unsaturated acyl radical of formula R3-CO-, in which R3. is an olefinically unsaturated copolymerisable radical having from 2 to 24 carbon atoms, preferably from 2 to 8 carbon atoms, especially preferably from 2 to 4 carbon atoms. In another embodiment the radical R2 is a radical of formula II
-CO-NH(R4-NH-CO-O)q-R5-O-CO-R3 (II) wherein q is zero or one and R4 and R5 are each independently lower alkylene having from 2 to 8 carbon atoms, arylene having from 6 to 12 carbon atoms, a saturated divalent cycloaliphatic group having from 6 to 10 carbon atoms, arylenealkylene or alkylenearylene having from 7 3b to 14 carbon atoms or arylenealkylenearylene having from 13 to 16 carbon atoms, and R3 is as defined above.
The prepolymer according to the invention of the divisional application is therefore especially a derivative of a polyvinyl alcohol having a molecular weight of at least about 2000 that, based on the number of hydroxy groups of the polyvinyl alcohol, comprises from approximately 0.5 to approximately 80~ of units of formula III
/CH2\ ~CH2~
CH CH
cu-~) o~~ o R- N~ [CO-NH-(R a-NH-CO-O) ~-R 5-O]p-CO-R 3 wherein R is lower alkylene, R1 is hydrogen or lower alkyl, p is zero or one, q is zero or one, R3 is an olefinically unsaturated copolymerisable radical having from 2 to 8 carbon atoms and R4 and RS are each independently lower alkylene having from 2 to 8 carbon atoms, arylene having from 6 to 12 carbon atoms, a saturated divalent cycloaliphatic group having from 6 to 10 carbon atoms, arylenealkylene or alkylenearylene having from 7 to 14 carbon atoms or arylenealkylenearylene having from 13 to 16 carbon atoms.
Lower alkylene R preferably has up to 8 carbon atoms and may be straight-chained or branched. Suitable examples include octylene, hexylene, pentylene, butylene, propylene, ethylene, methylene, 2-propylene, 2-butylene and 3-pentylene. Preferably lower alkylene R has up to 6 and especially preferably up to 4 carbon atoms. The meanings methylene and butylene are especially preferred.
Rt is preferably hydrogen or lower alkyl having up to seven, especially up to four, carbon atoms, especially hydrogen.
Lower ~kylene R4 or RS preferably has from 2 to 6 carbon atoms and is especially straight-chained. Suitable examples include propylene, butylene, hexylene, dimethyl-ethylene and, especially preferably, ethylene.
Arylene R4 or RS is preferably phenylene that is unsubstituted or is substituted by lower alkyl or lower alkoxy, especially 1,3-phenylene or 1,4-phenylene or methyl-1,4-phenylene.
A saturated divalent cycloaliphatic group R4 or RS is preferably cyclohexylene or cyclo-hexylene-lower alkylene, for example cyclohexylenemethylene, that is unsubstituted or is substituted by one or more methyl groups, such as, for example, trimethylcyclohexylene-methylene, for example the divalent isophorone radical.
The arylene unit of alkylenearylene or arylenealkylene R4 or RS is preferably phenylene, unsubstituted or substituted by lower alkyl or lower alkoxy, and the alkylene unit thereof is preferably lower alkylene, such as methylene or ethylene, especially methylene. Such radicals R4 or RS are therefore preferably phenylenemethylene or methylenephenylene.
Arylenealkylenearylene R4 or RS is preferably phenylene-lower alkylene-phenylene having up to 4 carbon atoms in the alkylene unit, for example phenyleneethylene-phenylene.
_,.
The radicals R't and RS are each independently preferably lower alkylene having from 2 to G carbon atoms, phenylene, unsubstituted or substituted by lower alkyl, cyclohexylene or cyclollexylene-lower alkylene, unsubstituted or substituted by lower alkyl, phenylene-lowcr alkylene, lower alkylerle-pllenylene or pllenylene-lower alkylene-phenylenc.
Within the scope of this invention, the term "lower" used in connection with radicals and compounds denotes radicals or compounds having up to 7 carbon atoms, preferably up to 4 carbon atoms, unless defined otherwise.
Lower alkyl has especially up to 7 carbon atoms, preferably up to 4 carbon atoms, and is, for example, methyl, ethyl, propyl, butyl or tcrt-butyl.
Lower alkoxy leas especially up to 7 carbon atoms, preferably up to 4 carbon atoms, and is, for example, mellloxy, etlloxy, propoxy, butoxy or tort-butoxy. _ 'hhe oleClnically unsaturated copolymerisable radical R3 having from 2 to 24 carbon atoms is preferably alkenyl having from 2 to 24 carbon atoms, especially alkcnyl having from 2 to S Carbon atUrllS and especially preferably alkenyl having from 2 to 4 carbon atoms, for cxarnplc etllcnyl, 2-prol~cnyl, 3-Ilropcnyl, 2-butcrryl, Ilcxcnyl, ocacnyl or dodcccnyl. l~Irc rncanings elllerlyl and 2-propenyl arc preferred, so that the group -CO-R3 is the acyl radical of acrylic or mctflacrylic acid.
'the divalent group -R'~-NI-i-CO-O- is pr~csent wllcn q is one and absent when q is zero.
1'repolymcrs in which q is zero are preferred.
'1'he divalent group -CO-NI-i-(R4-NI-I-CO-O)q-RS-O- is present when p is one and absent when p is zero. I'repolymers in which p is zero are preferred.
In pI-epUlynlCIS 111 Wl1IC11 p is ogle the index q is preferably zero.
Prepolymers in which p is one, the index q is zero and RS is lower alkylenc arc especially preferred.
~prefcrredprcpolynler_ is therefore especially a derivative of a polyvinyl alcohol having a molecular weight of at least about 2000 that, based on the number of hydroxy groups of the polyvinyl alcohol, comprises from approximately 0.5 to approxinlatcly 80 °lo of units of formula I1I in which R is lower alkylene having up to G
carbon atoms, p is zero and R~ is alkcnyl having from 2 to 8 ctu-bon acorns.
~e~
-G-A further preferred prepolymer, is therefore especially a deriv-alive of a polyvinyl alcohol having a molecular weight of at least about 2000 that, based Uil tllC IIUITIbcr of leydroxy groups of tile polyvinyl alcullol, colnpriscs from approxilnately U.5 to approximately 80 % of units of formula 1II in which R is lower alkylcne having up to G carbon atoms, p is one, d is zero, RS is lower alkylene leaving from 2 to G ctu-bon atoms and R3 is alkcllyl leaving froln 2 to 8 carbon atoms.
A further preferred prepolymcr, is therefore especial ly a deriv-alive of a polyvinyl alcohol having a molecular weight of at least about 2000 that, based on tile number of hydroxy groups of tile polyvinyl alcohol, comprises from approxilnatcly U.5 to approxinlatcly 8U % of units of formula Ill in wllicle R is lower alkylele leaving up to G carbon atoms, p 1S UI1C, q is one, R't is lower alkylene leaving from 2 to G carbon atoms, pleenylene, unsubstiwted or substituted by lower alkyl, cycloleexylenc or cyclo-hexylcne-lower alkylcne, unsubstitutcd or substituted by lower alkyl, phenylcne-lower alkylenc, lower alkylcnc-phenylenc or phenylenc-lower alkylcnc-phenylenc, RS
is lower alkylcne leaving from 2 to G carbon atoms and R3 is alkenyl having from 2 to 8 carbon atUteeS.
'flee prcpolyrncrs are preferably derivat ives of polyvinyl alcohol leaving a molecular weight of at least about 2000 that, based on the number of hydroxy groups of the polyvinyl alcohol, comprises from approximately 0.5 to approximately 8U
%, especially MpprUX1111atCly fr0111 1 to SU %, preferably approximately from 1 to 25 %, preferably aleproxineately from 2 to 15 % and especially preferably approximately front 3 to lo %, of units of formula III. I'repolylners according to tile invention which arc Ilrovided for tile Illaleufacture of contact Icllses comprise, based on tile number of Ilydroxy groups of the polyvinyl alcohol, especially from approximately 0.5 to approximately 25 %, especially approximately from 1 to 15 % and especially preferably approximately from 2 to 12 %, of units of forlnula III.
Polyvinyl alcohols that can be derivatised in accordance with the invention preferably leave a molecular weight of at least 10 UUU. As an upper limit tile polyvinyl alcollols may have a neoleculalr weight of up to 1 UUO UOU. Preferably, the polyvinyl alcollols (lave a molecular wciglet of up to 300 UUU, especially up to approximately IUU UUU and especially preferably up to approximately SU UUU.
-7_ Polyvinyl alcohols suitable in accordance with the invention usually have a poly(2-hydroxy)ethylene structure. The polyvinyl alcohols derivatised in accordance with the invention may, however, also comprise hydroxy groups in the form of 1,2-glycols, such as copolymer units of 1,2-dihydroxyethylene, as may be obtained, for example, by the alkaline hydrolysis of vinyl acetate/vinylene carbonate copolymers.
In addition, the polyvinyl alcohols derivatised in accordance with the invention may also comprise small proportions, for example up to 20 %, preferably up to 5 %, of copolymer units of ethylene, propylene, acrylamide, methacrylamide, dimethacrylamide, hydroxy-ethyl methacrylate, methyl methacrylate, methyl acrylate, ethyl acrylate, vinylpyrrolidone, hydroxyethyl acrylate, allyl alcohol, styrene or similar customarily used comonomers.
Commercially available polyvinyl alcohols may be used, such as, for example, Vinol~
107 produced by Air Products (MW = 22 000 to 31 000, 98 - 98.8 % hydrolysed), Polysciences 4397 (MW = 25 000, 98.5 % hydrolysed), BF 14 produced by Chan Chun, Elvanol~ 90 - SO produced by DuPont, UF-120 produced by Unitika, Moviol~ 4-88, 10-98 and 20-98 produced by Hoechst. Other manufacturers are, for example, Nippon Gohsei (Gohsenol~), Monsanto (Gelvatol~), Wacker (Polyviol~) and the Japanese manufacturers Kuraray, Denki and Shin-Etsu.
As already mentioned, it is also possible to use copolymers of hydrolysed vinyl acetate, which are obtainable, for example, in the form of hydrolysed ethylene/vinyl acetate (EVA), or vinyl chloride/vinyl acetate, N-vinylpyrrolidone/vinyl acetate and malefic acid anhydride/vinyl acetate.
Polyvinyl alcohol is usually prepared by hydrolysis of the corresponding homopolymeric polyvinyl acetate. In a preferred embodiment, the polyvinyl alcohol derivatised in accordance with the invention comprises less than 50 % of polyvinyl acetate units, especially less than 20 % of polyvinyl acetate units. Preferred amounts of residual acetate units in the polyvinyl alcohol derivatised in accordance with the invention, based on the sum of vinyl alcohol units and acetate units, are approximately from 3 to 20 %, preferably approximately from 5 to 16 % and especially approximately from 10 to 14 %.
The compounds comprising units of formula III may be prepared in a manner known her se. For example, a polyvinyl alcohol having a molecular weight of at least about 2000 that comprises units of formula IV
_g_ -CH(OH)-CH2- (IV) may be reacted with approximately from 0.5 to 80 %, based on the number of hydroxy groups of the compound of formula IV, of a compound of formula (V) R' R"
O~ CH ~O
R~
N /
[CO-NH-(R4-NH-CO-O)q-RS-O]P-CO-R3 in which R' and R" are each independently hydrogen, lower alkyl or lower alkanoyl, such as acetyl or propionyl, and the other variables are as defined for formula III, especially in an acidic medium.
Alternatively, a polyvinyl alcohol having a molecular weight of at least about 2000 that comprises units of formula IV may be reacted with a compound of formula VI
R' R"
O~ CH ~O (VI) R~
N /
~W
in which the variables are as defined for the compound of formula V, especially under acidic conditions, and the cyclic acetal obtainable in that manner may then be reacted with a compound of formula VII
OCN-(R4-NH-CO-O)q RS-O-CO-R3 (VII) in which the variables are as defined for the compound of formula V.
Alternatively, the product obtainable as described above from a compound of formula IV
and a compound of formula VI may be reacted with a compound of formula (VIII) X-CO-R3 (VIB) in which R3 is, for example, alkenyl having from 2 to 8 carbon atoms and X is a reactive group, for example etherified or esterified hydroxy, for example halogen, especially chlorine.
Compounds of formula V in which p is zero are known, for example, from EP 201 693.
Compounds of formula VI are also described therein. Compounds of formula VII
are known her se, or can be prepared in a manner known Qer se. An example of a compound of formula VII in which q is zero is isocyanatoethyl methacrylate. An example of a compound of formula VII in which q is one is the reaction product of isophorone diiso-cyanate with 0.5 equivalent of hydroxyethyl methacrylate. Compounds of formula VIII are known her se; a typical representative is methacryloyl chloride. Compounds of formula V
in which p and/or q are 1 can be prepared in a manner known ~ se from the above-mentioned compounds, for example by reaction of a compound of formula VI with iso-cyanatoethyl methacrylate or by reaction of a compound of formula VI with isophorone diisocyanate which has previously been terminated with 0.5 equivalent of hydroxyethyl methacrylate.
Surprisingly the prepolymers of formulae I and III are extraordinarily stable.
This is unexpected for the person skilled in the an because, for example, higher-functional acrylates usually have to be stabilised. If such compounds are not stabilised then rapid polymerisation usually occurs. Spontaneous crosslinking by homopolymerisation does not occur, however, with the prepolymers of the invention. The prepolymers of formulae I and III can furthermore be purified in a manner known her se, for example by precipitation with acetone, dialysis or ultrafrltration, ultrafiltration being especially preferred. By means of that purification process the prepolymers of formulae I and III can be obtained in extremely pure form, for example in the form of concentrated aqueous solutions that are free, or at least substantially free, from reaction products, such as salts, and from starting materials, such as, for example, compounds of formula V or other non-polymeric constituents.
- lU
The prefen~ed purification process for the prepolymers of the invention, ultrafiltration, cm be carried out in a nllulner known ~ se. It is possible for the ultrafiltration to be carried out repeatedly, for example from two to ten times. Alternatively, the ultrafiltration call be carried out CUIItIrIUUUSIy until tllc selected degree of purity is attained.
'hhc selected degree of purity can in principle be as higtl as desired. A suitable measure for the degree of purity is, for example, the sodium chloride content of the solution, which can be determined simply in known manner.
'1 he prepolymers of formulae I and III according to the invention are on the other hand crosslirlkable in as extremely effective and CUI1LIUIICd ItlaIlIICI, especially by photocross-linkirlg.
The present invention is therefore also directed to a polymer that can be obtained by photocrosslinking a prepolymer comprising units of formula I or III in the absence or presence of all addltlonal vinylic comonomer. 'Those polymers are water-insoluble.
In the case of photocrosslinking, it is appropriate to add a photoinitiator which cal initiate radical crosslinking. Cxamplcs thereof are familiar to the person skilled in the al-t and suitable photoinitiators lilac may be mentioned specifically are bcIlZUlrl IIICtllyl etfler, 1-llydroxycyclollexylpfrenyl ketone, Darocurc~1173 or Irgacurc types. 'I'lle crosslinking cars then be triggered by actinic radiation, such as, for example, UV light, or ionising radiation, such as, for cxa rnplc, gamma radiation or X-radiation.
The photopolymerisatiol is suitably carried out in a solvent. A suitable solvent is in principle any solvent that dissolves polyvinyl alcohol and the vinylic comonomers optionally used in addition, for example water, alcohols, such as lower alkalols, for example ctllallol or methanol, also carboxylic acid amides, such as dimethylformamide, or dilnethyl sulfoxide, and also a mixture of suitable solvents, such as, for example, a mixture of water with an alcohol, such as, for example, a water/ethallol or a water/-Illctha1101 mixture.
'the photocrosslinking is carried out preferably directly from an aqueous solution of the prepolymers according to the invention, which can be obtained by the preferred puriClca-tioll step, ultraGltration, where appropriate after the addition of an additional vinylic comonomer. I~or example, an approximately I5 to 4U % aqueous solution can be plloto-*Trade-mark crosslinked.
The process for the preparation of the polymers of the invention may comprise, for example, photocrosslinking a prepolymer comprising units of formula I or III, especially in substantially pure form, that is to say, for example, after single or repeated ultra-filtration, preferably in solution, especially in aqueous solution, in the absence or presence of an additional vinylic comonomer.
The vinylic comonomer which, in accordance with the invention, may be used in addition in the photocrosslinking, may be hydrophilic or hydrophobic, or a mixture of a hydro-phobic and a hydrophilic vinylic monomer. Suitable vinylic monomers include especially those customarily used in the manufacture of contact lenses. A hydrophilic vinylic monomer denotes a monomer that typically yields as homopolymer a polymer that is water-soluble or can absorb at least 10 % by weight of water. Analogously, a hydrophobic vinylic monomer denotes a monomer that typically yields as homopolymer a polymer that is water-insoluble and can absorb less than 10 % by weight of water.
Generally, approximately from 0.01 to 80 units of a typical vinylic comonomer react per unit of formula I or III.
If a vinylic comonomer is used, the crosslinked polymers according to the invention preferably comprise approximately from 1 to 15 %, especially preferably approximately from 3 to 8 %, of units of formula I or III, based on the number of hydroxy groups of the polyvinyl alcohol, which are reacted with approximately from 0.1 to 80 units of the vinylic monomer.
The proportion of the vinylic comonomers, if used, is preferably from 0.5 to 80 units per unit of formula I, especially from 1 to 30 units per unit of formula I, and especially preferably from 5 to 20 units per unit of formula I.
It is also preferable to use a hydrophobic vinylic comonomer or a mixture of a hydro-phobic vinylic comonomer with a hydrophilic vinylic comonomer, the mixture comprising at least 50 % by weight of a hydrophobic vinylic comonomer. In that manner the mechanical properties of the polymer can be improved without the water content falling substantially. In principle, however, both conventional hydrophobic vinylic comonomers and conventional hydrophilic vinylic comonomers are suitable for the copolymerisation with polyvinyl alcohol comprising groups of formula I.
Suitable hydrophobic vinylic comonomers include, without the list being exhaustive, Ct-Ctgalkyl acrylates and methacrylates, C3-Ctgalkyl acrylamides and methacrylamides, acrylonitrile, methacrylonitrile, vinyl-C1-Ctgalkanoates, C2-Cl8alkenes, C2-Ctghalo-alkenes, styrene, Ct-C6alkylstyrene, vinyl alkyl ethers, in which the alkyl moiety contains from 1 to 6 carbon atoms, C2-Ctoperfluoroalkyl acrylates and methacrylates or corres-pondingly partially fluorinated acrylates and methacrylates, C3-Ctzperfluoroalkyl-ethyl-thiocarbonylaminoethyl acrylates and methacrylates, acryloxy- and methacryloxy-alkylsil-oxanes, N-vinylcarbazole, Cl-Cl2alkyl esters of malefic acid, fumaric acid, itaconic acid, mesaconic acid and the like. Cl-C4alkyl esters of vinylically unsaturated carboxylic acids having from 3 to 5 carbon atoms or vinyl esters of carboxylic acids having up to S carbon atoms, for example, are preferred.
Examples of suitable hydrophobic vinylic comonomers include methyl acrylate, ethyl acrylate, propyl acrylate, isopropyl acrylate, cyclohexyl acrylate, 2-ethylhexyl acrylate, methyl methacrylate, ethyl methacrylate, propyl methacrylate, vinyl acetate, vinyl prop-ionate, vinyl butyrate, vinyl valerate, styrene, chloroprene, vinyl chloride, vinylidene chloride, acrylonitrile, 1-butene, butadiene, methacrylonitrile, vinyltoluene, vinyl ethyl ether, perfluorohexylethylthiocarbonylaminoethyl methacrylate, isobornyl methacrylate, trifluoroethyl methacrylate, hexafluoroisopropyl methacrylate, hexafluorobutyl meth-acrylate, tris-trimethylsilyloxy-silyl-propyl methacrylate, 3-methacryloxypropylpenta-methyldisiloxane and bis(methacryloxypropyl)tetramethyldisiloxane.
Suitable hydrophilic vinylic comonomers include, without the list being exhaustive, hydroxy-substituted lower alkyl acrylates and methacrylates, acrylamide, methacrylamide, lower alkyl acrylamides and methacrylamides, ethoxylated acrylates and methacrylates, hydroxy-substituted lower alkyl acrylamides and methacrylamides, hydroxy-substituted lower alkyl vinyl ethers, sodium ethylenesulfonate, sodium styrenesulfonate, 2-acryl-amido-2-methylpropanesulfonic acid, N-vinylpyrrole, N-vinylsuccinimide, N-vinylpyrrol-idone, 2- or 4-vinylpyridine, acrylic acid, methacrylic acid, amino- (the term "amino" also including quaternary ammonium), mono-lower alkylamino- or di-lower alkylamino-lower alkyl acrylates and methacrylates, allyl alcohol and the like. Hydroxy-substituted C2-C4-alkyl(meth)acrylates, five- to seven-membered N-vinyl lactams, N,N-di-Ct-C4alkyl-(meth)acrylamides and vinylically unsaturated carboxylic acids having a total of from 3 to carbon atoms, for example, are preferred.
Examples of suitable hydrophilic vinylic comonomers include hydroxyethyl methacrylate, hydroxyethyl acrylate, acrylamide, methacrylamide, dimethylacrylamide, allyl alcohol, vinylpyridine, vinylpyrrolidone, glycerol methacrylate, N-(1,1-dimethyl-3-oxobutyl)-acrylamide, and the like.
Preferred hydrophobic vinylic comonomers are methyl methacrylate and vinyl acetate.
Preferred hydrophilic vinylic comonomers are 2-hydroxyethyl methacrylate, N-vinyl-pyrrolidone and acrylamide.
The prepolymers according to the invention can be processed in a manner known her se into mouldings, especially contact lenses, for example by carrying out the photocrosslinldng of the prepolymers according to the invention in a suitable contact lens mould. The invention is therefore also directed to mouldings that consist substantially of a polymer according to the invention. Further examples of mouldings according to the invention, besides contact lenses, are biomedical or especially ophthalmic mouldings, for example intraocular lenses, eye bandages, mouldings that can be used in surgery, such as heart valves, artificial arteries or the like, and also films or membranes, for example membranes for diffusion control, photostructurizable films for information storage, or photoresist materials, for example membranes or mouldings for etch resist or screen printing resist.
A special embodiment of the invention is directed to contact lenses that comprise a polymer according to the invention or consist substantially or wholly of a polymer according to the invention. Such contact lenses have a wide range of unusual and extremely advantageous properties, which include, for example, their excellent compat-ibility with the human cornea, which is based on a balanced relationship of water content, oxygen permeability and mechanical properties. The contact lenses according to the invention furthermore exhibit a high degree of dimensional stability. No changes in shape are detected even after autoclaving at, for example, about 120°C.
Attention may also be drawn to the fact that the contact lenses according to the invention, which means especially those comprising a polymer based on a prepolymer comprising units of formula I, can be produced in a very simple and efficient manner compared with the state of the art. This is as a result of several factors. First, the starting materials can be obtained or produced at a favourable cost. Secondly, there is the advantage that the prepolymers are surprisingly stable, so that they can be subjected to a high degree of purification. It is therefore possible to use for the crosslinking a prepolymer that requires practically no subsequent purification, such as especially a complicated extraction of unpolymerised constituents. Also, the polymerisation can be carried out in aqueous solution, so that a subsequent hydration step is not necessary. Finally, the photopolymerisation occurs within a short period, so that the process for manufacturing the contact lenses according to the invention can be organised to be extremely economical from that point of view also.
All of the advantages mentioned above naturally apply not only to contact lenses but also to other mouldings according to the invention. Taking into account all the various advant-ageous aspects in the manufacture of the mouldings~according to the invention it can be seen that the mouldings according to the invention are especially suitable as mass-produced articles, such as, for example, contact lenses that are worn for a short time and then replaced by new lenses.
The present invention also relates to the manufacture of mouldings according to the invention, especially contact lenses according to the invention. In the following, those processes are illustrated using the example of contact lenses, but the processes can, however, also be used for other mouldings according to the invention.
The contact lenses according to the invention can be manufactured, for example, in a manner known her se, for example in a conventional "spin-casting mould", as described, for example, in US-A-3 408 429, or by the so-called Full-Mould process in a static mould, as described, for example, in US-A-4 347 198.
It has been ascertained in accordance with the invention that the process described above with reference to prepolymers comprising units of formula I can be applied generally. The Rresent invention therefore relates to a novel process for the manufacture of polymeric mouldings, especially contact lenses, in which a water-soluble prepolymer comprising crosslinkable groups is crosslinked in solution, and to mouldings, especially contact lenses, obtainable in accordance with that process. The mouldings obtainable in that manner by crosslinking are water-insoluble but are swellable in water.
In detail, the process for the manufacture of mouldings, especially contact lenses, comprises the following steps:
a) the preparation of a substantially aqueous solution of a water-soluble prepolymer that comprises crosslinkable groups, b) the introduction of the solution obtained into a mould, c) the triggering of the crosslinking, d) opening of the mould such that the moulding can be removed from the mould.
Unless expressly excluded hereinafter, the detailed explanations and preferences disclosed hereinbefore in connection with prepolymers comprising units of formula I, and also the detailed explanations and preferences disclosed in connection with the processes for the production of polymers and mouldings, such as, especially, contact lenses, from those pre-polymers, apply also to the process comprising steps a), b), c) and d) described in the above paragraph. This statement applies to all cases in which the detailed explanations and preferences in connection with prepolymers comprising units of formula I can sensibly be applied to the process described in the above paragraph.
The decisive criteria determining the suitability of a prepolymer for use in the process according to the invention are that the prepolymer is soluble in water and that it comprises crosslinkable groups.
The preparation of a substantially aqueous solution of a water-soluble prepolymer that comprises crosslinkable groups can be carried out in a manner known ~ se, for example by synthesis of the prepolymer in a substantially aqueous solution or by isolation of the prepolymer for example in pure form, which means free from undesired constituents, and dissolution thereof in a substantially aqueous medium.
In accordance with the invention, the criterion that the prepolymer is soluble in water denotes in particular that the prepolymer is soluble in a concentration of approximately from 3 to 90 % by weight, preferably approximately from 5 to 60 % by weight, especially approximately from 10 to 60 % by weight, in a substantially aqueous solution.
Insofar as it is possible in an individual case, prepolymer concentrations of more than 90 %
are also included in accordance with the invention. Especially prefert-ed concentrations of the prepolymer in solution are from approximately 15 to approximately 50 % by weight, especially from approximately 15 to approximately 40 % by weight, for example from approximately 25 % to approximately 40 % by weight.
Within the scope of this invention, substantially aqueous solutions of the prepolymer comprise especially solutions of the prepolymer in water, in aqueous salt solutions, especially in aqueous salt solutions that have an osmolarity of approximately from 200 to 450 milliosmol per 1000 ml (unit: mOsm/1), preferably an osmolarity of approximately from 250 to 350 mOsm/l, especially approximately 300 mOsm/1, or in mixtures of water or aqueous salt solutions with physiologically tolerable polar organic solvents, such as, for example, glycerol. Solutions of the prepolymer in water or in aqueous salt solutions are preferred.
The aqueous salt solutions are advantageously solutions of physiologically tolerable salts, such as buffer salts customary in the field of contact lens care, for example phosphate salts, or isotonising agents customary in the field of contact lens care, such as, especially, alkali halides, for example sodium chloride, or solutions of mixtures thereof.
An example of an especially suitable salt solution is an artificial, preferably buffered, lacrimal fluid that in respect of pH value and osmolarity is adapted to natural lacrimal fluid, for example a sodium chloride solution that is unbuffered or that is preferably buffered, for example, by phosphate buffer, and that has an osmolarity that corresponds to the osmolarity of human laclimal fluid.
The substantially aqueous solution of the prepolymer defined hereinbefore is preferably a pure solution which means a solution which is free or essentially free from undesired constituents. Especially preferred examples of such solutions are a solution of the prepolymer in pure water or in an artificial lacrimal fluid, as defined hereinbefore.
The viscosity of the solution of the prepolymer in the substantially aqueous solution is, within wide limits, not critical, but the solution should preferably be a flowable solution that can be deformed strain-free.
The molecular weight of the prepolymer is also, within wide limits, not critical.
Preferably, however, the prepolymer has a molecular weight of from approximately 000 to approximately 200 000.
The prepolymer used in accordance with the invention must furthermore comprise cross-linkable groups. "Crosslinkable groups" denotes customary crosslinkable groups well-known to the person skilled in the art, such as, for example, photocrosslinkable or thermally crosslinkable groups. Crosslinkable groups such as those already proposed for the preparation of contact lens materials are especially suitable. Those include especially, but not exclusively, groups comprising carbon-carbon double bonds. To demonstrate the large variety of suitable crosslinkable groups, there are mentioned here, merely by way of example, the following crosslinking mechanisms: radical polymerisation, 2+2 cyclo-addition, Diels-Alder reaction, ROMP (Ring Opening Metathesis Polymerisation), vulcan-isation, cationic crosslinking and epoxy hardening.
Suitable water-soluble prepolymers that comprise crosslinkable groups are, for example, compounds comprising units of formula I. It is also possible, however, to use in the process other water-soluble prepolymers that comprise a polymeric backbone and also crosslinkable groups.
Suitable polymeric backbones include, besides polyvinyl alcohol, materials such as those already proposed in some cases as contact lens materials, for example polymeric diols other than PVA, polymers comprising saccharides, polymers comprising vinylpyrrolidone, polymers comprising alkyl(meth)acrylates, polymers comprising alkyl(meth)acrylates that have been substituted by hydrophilic groups, such as by hydroxy, carboxy or by amino, polyalkylene glycols, or copolymers or mixtures thereof.
The prepolymer used in accordance with the invention preferably comprises crosslinkable groups in an amount of from approximately 0.5 to approximately 80 %
equivalents, based on the equivalents of monomers that form the polymeric backbone, especially approx-imately from 1 to 50 %, preferably approximately from 1 to 25 %, preferably approx-imately from 2 to 15 % and especially preferably approximately from 3 to 10 %.
Also especially preferred are amounts of crosslinkable groups of from approximately 0.5 to approximately 25 % equivalents, especially approximately from 1 to 15 % and especially preferably approximately from 2 to 12 %, based on the equivalents of monomers that form the polymeric backbone.
As already mentioned, an essential criterion for the suitability of a prepolymer for the process according to the invention is that it is a crosslinkable prepolymer, but the pre-polymer is uncrosslinked, or at least substantially uncrosslinked, so that it is water-soluble.
- 1g -In addition, the prepolymer is advantageously stable in the uncrosslinked state, so that it can be subjected to purification as described hereinbefore in connection with compounds comprising units of formula I. The prepolymers are preferably used in form of a pure solution in the process according to the invention. The prepolymers can be converted into the form of a pure solution for example in the manner disclosed hereinafter.
Preferably, the prepolymers used in the process according to the invention can be purified in a manner known ~ se, for example by precipitation with organic solvents, such as acetone, filtration and washing, extraction in a suitable solvent, dialysis or ultrafiltration, ultrafiltration being especially preferred. By means of that purification process the pre-polymers can be obtained in extremely pure form, for example in the form of concentrated aqueous solutions that are free, or at least substantially free, from reaction products, such as salts, and from starting materials, such as, for example, non-polymeric constituents.
The preferred purification process for the prepolymers used in the process according to the invention, ultraftltration, can be carried out in a manner known her se. It is possible for the ultrafiltrarion to be carried out repeatedly, for example from two to ten times.
Alternatively, the ultrafiltration can be carried out continuously until the selected degree of purity is attained. The selected degree of purity can in principle be as high as desired. A
suitable measure for the degree of purity is, for example, the sodium chloride content of the solution, which can be determined simply in known manner.
In a preferred embodiment of the process according to the invention there is prepared in step a) and further used in the process a substantially aqueous solution of the prepolymer that is substantially free from undesired constituents, such as, for example, free from monomeric, oligomeric or polymeric starting compounds used for the preparation of the prepolymer, and/or free from secondary products formed during the preparation of the prepolymer. The substantially aqueous solution is more preferably a pure aqueous solution or a solution in an artificial lacrimal fluid, as defined hereinbefore. It is also preferable to carry out the process according to the invention without the addition of a comonomer, for example a vinylic comonomer.
On the basis of one of the measures mentioned in the above paragraph, and especially on the basis of a combination of the measures mentioned in the above paragraph, the solution of the prepolymer used in the process according to the invention is one that comprises no, or substantially no, undesired constituents that would have to be extracted after a crosslinking operation. A particular feature of this preferred embodiment of the process according to the invention is therefore that the extraction of undesired constituents follow-ing crosslinking can be dispensed with.
The process according to the invention is therefore preferably carried out in such a manner that the substantially aqueous solution of the water-soluble prepolymer comprising cross-linkable groups is free or substantially free of undesired constituents, such as especially monomeric, oligomeric or polymeric starting compounds used for the preparation of the prepolymer, or secondary products that have formed during the preparation of the prepolymer, and/or that the solution is used without the addition of a comonomer, so that the extraction of any undesired constituents in the further course of the process can be dispensed with.
One additive that is added, where appropriate, to the solution of the prepolymer is an initiator for the crosslinking, should an initiator be required for crosslinking the cross-linkable groups. That may be the case especially if the crosslinking is carried out by photocrosslinking, which is preferred in the process according to the invention.
In the case of photocrosslinking, it is appropriate to add a photoinitiator which can initiate radical crosslinldng. Examples thereof are familiar to the person skilled in the art and suitable photoinitiators that may be mentioned specifically are benzoin methyl ether, 1-hydroxycyclohexylphenyl ketone, or a commercial product such as Darocure- or Irgacure types, e.g. Darocure 1173 or Irgacure 2959.
Methods that are known her se, such as, especially, conventional metering in, for example by dropwise introduction, may be used to introduce the resulting solution into a mould.
Suitable moulds are generally customary contact lens moulds as known in the state of the art. Thus, the contact lenses according to the invention can be manufactured, for example, in a manner known ~ se, for example in a conventional "spin-casting mould", as described, for example, in US-A-3 408 429, or by the so-called Full-Mould process in a static mould, as described, for example, in US-A-4 347 198. Appropriate moulds are made, for example, from polypropylene. Quartz, sapphire glass and metals, for example, are suitable materials for re-usable moulds.
The crosslinking can be triggered in the mould, for example by actinic radiation, such as, for example, UV light, or by ionising radiation, such as, for example, gamma radiation, electron radiation or X radiation. The crosslinking can where appropriate also be triggered thermally. Attention is drawn to the fact that the crosslinking can be carried out according to the invention in a very short time, for example in less than five minutes, preferably in less than one minute, especially in up to 30 seconds, especially preferably, as disclosed in the examples.
The opening of the mould such that the moulding can be removed from the mould can be carried out in a manner known per se. Whereas in processes that have been proposed in the state of the art it is usually necessary at that point for purification steps to follow, for example extraction, and also steps for the hydration of the resulting mouldings, especially contact lenses, such steps are not necessary in the process according to the invention.
Since the solution of the prepolymer preferably does not comprise any undesired low-molecular constituents, the crosslinked product, too, does not comprise any such constituents. Therefore subsequent extraction is not necessary. Since the crosslinking is carried out in a substantially aqueous solution, subsequent hydration is not necessary.
Those two advantages mean, inter alia, that a complicated after-treatment of the resulting mouldings, especially contact lenses, is dispensed with. The contact lenses obtainable in accordance with the process according to the invention are therefore, according to an advantageous embodiment, distinguished by the fact that they are suitable for their intended use without extraction. "Intended use" in this context means especially that the contact lenses can be used in the human eye. The contact lenses obtainable in accordance with the process according to the invention are, according to an advantageous embodi-ment, also distinguished by the fact that they are suitable for their intended use without hydration.
The process according to the invention is therefore outstandingly well suited to the economical manufacture of a large number of mouldings, such as contact lenses, in a short time. The contact lenses obtainable in accordance with the process according to the invention have inter alia the advantages over the contact lenses known from the state of the art that they can be used for their intended use without subsequent treatment steps, such as extraction or hydration.
In the following Examples, unless expressly stated otherwise amounts are amounts by weight, and temperatures are in degrees Celsius. The Examples are not intended to limit the invention in any way, for instance to the scope of the Examples.
Example la): Over a period of 4 hours, 104.5 parts of methacryloyl chloride dissolved in 105 parts of dichloromethane are added dropwise at a maximum of 15°C, while cooling with ice, to 105.14 pans of aminoacetaldehyde dimethylacetal and 101.2 parts of triethyl-amine in 200 parts of dichloromethane. When the reaction is complete, the dichloro-methane phase is washed with 200 parts of water then with 200 parts of 1N HCl solution, and then twice with 200 parts of water. After drying with anhydrous magnesium sulfate, the dichloromethane phase is concentrated by evaporation and stabilised with 0.1 % of 2,6-di-tert-butyl-p-cresol, based on the reaction product. After distillation at 90°C/10'3 mbar, 112 g of methacrylamidoacetaldehyde dimethylacetal are obtained in the form of a colourless liquid, boiling point 92°C/10-3 mbar (65 % yield).
Example 1b): 52.6 g of aminoacetaldehyde dimethylacetal are dissolved in 150 ml of deionised water and cooled to 5°C with ice. Subsequently, 50 ml of methacrylic acid chloride and 50 ml of 30 % sodium hydroxide solution are simultaneously so added over a period of 40 minutes that the pH value remains at 10 and the temperature does not exceed 20°C. When the addition is complete, the remaining content of aminoacetaldehyde dimethylacetal is determined as 0.18 % by gas chromatography. The amine is reacted fully by the further addition of 2.2 ml of methacrylic acid chloride and 2.0 ml of 30 % sodium hydroxide solution. The solution is then neutralised with 1 N hydrochloric acid (pH = 7).
The aqueous phase is extracted with 50 ml of petroleum ether and washed with water. The petroleum ether phase contains 3.4 g of secondary product. The aqueous phases are combined and yield 402.8 g of a 20.6 % solution of methacrylamidoacetaldehyde dimethylacetal. According to a gas chromatogram, the product is 98.2 %.
Example 2: 10 parts of polyvinyl alcohol having a molecular weight of 22 000 and a degree of hydrolysis of 97.5 - 99.5 % are dissolved in 90 parts of water, 2.5 parts of meth-acrylamidoacetaldehyde dimethylacetal are added and the mixture is acidified with parts of concentrated hydrochloric acid. The solution is stabilised with 0.02 parts of 2,6-di-tert-butyl-p-cresol. After stirring for 20 hours at room temperature, the solution is adjusted to pH 7 with 10 % sodium hydroxide solution and then ultrafiltered seven times using a 3kD membrane (ratio 1:3). After concentration, an 18.8 % aqueous solution of methacrylamidoacetaldehydo-1,3-acetal of polyvinyl alcohol having a viscosity of 2240 cP at 25°C is obtained.
Example 3: 10 parts of the solution of methacrylamidoacetaldehydo-1,3-acetal of polyvinyl alcohol obtained in accordance with Example 2 are photochemically crosslinked by adding 0.034 parts of Darocure 1173 (CIBA-GEIGY) thereto. The mixture is irradiated in the form of a 100 micron thick layer between two glass plates with 200 pulses of a 5000 watt irradiation device produced by Staub. A solid transparent film with a solids content of 31 % is obtained.
Example 4: 110 g of polyvinyl alcohol (Moviol 4-88, Hoechst) are dissolved at 90°C in 440 g of deionised water and cooled to 22°C. 100.15 g of a 20.6 %
aqueous solution of methacrylamidoacetaldehyde dimethylacetal, 38.5 g of concentrated hydrochloric acid (37 % p.a., Merck) and 44.7 g of deionised water are added thereto. The mixture is stirred at room temperature for 22 hours and then adjusted to pH 7.0 with a 5 % NaOH
solution.
The solution is diluted to 3 litres with deionised water, filtered and ultrafiltered using a 1-KD-Omega membrane produced by Filtron. After the three-fold specimen volume has permeated, the solution is concentrated. 660 g of a 17.9 % solution of the methacrylamido-acetaldehydo-1,3-acetal of polyvinyl alcohol having a viscosity of 210 cp are obtained.
The inherent viscosity of the polymer is 0.319. The nitrogen content is 0.96 %. According to NMR investigation, 11 mol % of the OH groups have been acetalised and 5 mol % of the OH groups acetylated. Concentration of the aqueous polymer solution under reduced pressure and with air draft yields a 30.8 % solution having a viscosity of 3699 cp.
Example 5: 66.6 g of deionised water, 3.3 g of monomeric 4-methacrylamidobutyr-aldehyde diethylacetal and 20.0 g of concentrated hydrochloric acid (37 %
p.a., Merck) are added to 133.3 g of a 15 % polyvinyl alcohol solution (Moviol 4-88, Hoechst) and the mixture is stirred at room temperature for 8 hours. The solution is then adjusted to pH 7 with 5 % sodium hydroxide solution. After ultrafiltration of the solution using a 3-KD-Omega membrane produced by Filtron, the sodium chloride content of the polymer solution being reduced from 2.07 % to 0.04 %, a 20 % polymer solution of the methacryl-amidobutyraldehydo-1,3-acetal of polyvinyl alcohol having a viscosity of 400 cp is obtained. The inherent viscosity of the polymer is 0.332. The nitrogen content is 0.41 %.
According to NMR investigation, 7.5 mol % of the OH groups are charged with acetal groups and 7.3 mol % of the OH groups are charged with acetate groups.
Example 6: 2.4 g (14.8 mmol) of aminobutyraldehyde diethylacetal (Fluka) and 20 g of concentrated hydrochloric acid (37 % p.a., Merck) are added to 200 g of a 10 %
polyvinyl alcohol solution (Moviol 4-88, Hoechst). The solution is stirred at room temperature for 48 hours and then neutralised with 10 % sodium hydroxide solution. The solution is diluted to 400 ml. 200 ml of the solution are further processed in accordance with Example 7. 0.85 g (8.1 mmol) of methacrylic acid chloride (Fluka) is added to the remaining 200 ml of the solution and the pH value is maintained at 10 with 2N
sodium hydroxide solution. After 30 minutes at room temperature, the pH is adjusted to 7.0 and the solution is purified analogously to Example 5 using a 3-KD-Omega membrane produced by Filiron. Concentration yields a 27.6 % polymer solution of the methacryl-amidobutyraldehydo-1,3-acetal of polyvinyl alcohol having a viscosity of 2920 cp. The inherent viscosity of the polymer is 0.435. The nitrogen content is 0.59 ~'o.
Example 7: 1.3 g (8.5 mmol) of 2-isocyanatoethyl rnethacrylate are added to 200 ml of the polymer solution of Example 6 and the pH maintained at 10 with 2N sodium hydroxide solution. After 15 minutes at room temperature the solution is neutralised with 2N hydro-chloric acid and ultrafiltered analogously to Example 6. Concentration yields a 27.1 %
polymer solution of the 4-(2-methacryloylethyl-ureido)butyraldehydo-1,3-acetal of poly-vinyl alcohol having a viscosity of 2320 cp. The inherent viscosity of the polymer is 0.390. The nitrogen content is 1.9 %.
Example 8: 0.7 % Darocure 1173 (based on the content of polymer) is added to the 30.8 %
polymer solution according to Example 4 having a viscosity of approximately 3600 cp.
The solution is introduced into a transparent contact lens mould of polypropylenevand the mould is closed. The solution is irradiated for 6 seconds from a distance of 18 cm using a 200 watt OrielTM LTV lamp. The mould is opened and the finished contact lens can be removed. The contact lens is transparent and has a water content of 61 %. The modulus is 0.9 mPa, the flexural elongation 50 %. The contact lens is autoclaved for 40 minutes at 121°C. No changes in shape can be detected in a contact lens treated in that manner.
Examyle 9: 0.0268 g of Darocure 1173 (0.7 % based on the polymer content) and 0.922 g of methyl methacrylate are added to 10.00 g of a 27.1 % polymer solution according to Example 7. After the addition of 2.3 g of methanol a clear solution is obtained. That solution is irradiated for a period of 14 seconds analogously to Example 8, using a 200 watt OrieITM lamp. A transparent contact lens having a water content of 70.4% is obtained.
Example 10: 1.04 g of acrylamide and 0.03 g of Darocure 1173 are added to 12.82 g of a 24.16 % solution of the prepolymer of Example 4. The clear solution is then irradiated for 14 seconds analogously to Example 8, using a 200 watt Oriel T"" lamp. A
contact lens having a water content of 64.4 % is obtained.
Example 11: 220 g (5.5 mol) of sodium hydroxide are dissolved in 300 g of water and 700 g of ice in a 3-litre reactor having a stirrer and a cooling system. The sodium hydroxide solution is cooled to 10°C and 526 g (5.0 mol) of aminoacetaldehyde dimethyl-acetal and 50 mg of 4-hydroxy-2,2,6,6-tetramethylpiperidin-1-oxide (radical inhibitor) are added. 548.6 g (5.5 mol) of methacrylic acid chloride are slowly added at 10°C to the solution over a period of 3.5 hours. When the addition is complete, the pH
value drops slowly to 7.2 and amine can no longer be detected by GC. The reaction mixture is extracted with 500 ml of petroleum ether, and in order to remove impurities, the aqueous phase is saturated with sodium chloride and extracted three times with 500 ml of tent-butyl methyl ether. The organic phase is dried with magnesium sulfate, filtered and concentrated using a rotary evaporator. The resulting 882.2 g of yellowish oil are slowly stirred into 2000 ml of petroleum ether at -10°C by means of an Ultraturax. The product crystallises, and is isolated by filtration and dried. 713.8 g of methacrylamidoacetaldehyde dimethyl-acetal (86 % of theory), melting point 30-32°C, are obtained; the product is 99.7 %
according to GC.
Example 12: 40 g (1.0 mol) of sodium hydroxide are dissolved in 100 g of water and 200 g of ice in a 1-litre reactor having a stirrer and a cooling system. The sodium hydroxide solution is cooled to 10°C, and 105.1 g (1.0 mol) of aminoacetaldehyde dimethylacetal and 10 mg of the inhibitor 4-hydroxy-2,2,6,6-tetramethylpiperidin-1-oxide ane added.
99.5 g (1.1 mol) of acrylic acid chloride are slowly added to that solution at 10°C over a period of 2 hours. The pH value drops slowly and ultimately is adjusted to 7.
According to GC, amine is no longer present. The reaction mixture is saturated with sodium chloride and extracted three times with 200 ml of ten-butyl methyl ether. The organic phase is dried, filtered and concentrated using a rotary evaporator. The resulting oil is extracted three times with petroleum ether and then dried again using a rotary evaporator. 130~g of acrylamidoacetaldehyde dimethylacetal (81 % of theory) are obtained in the form of an oil; the product is 99 % according to GC.
Example 13: General preparative method for the reaction of PVA with acetals or aldehydes for the preparation of reaction products having a high acetate content 300 g of PVA (for example Moviol Hoechst 4-88) are placed in a 2-litre double jacket reactor having a stirrer and thermometer, 800 g of deionised water are added, and the mixture is heated to 95°C with stirring. After one hour, everything has dissolved to produce a clear solution which is cooled to 20°C. 27 g (0.155 mol) of methacrylamido-acetaldehyde dimethyl acetal (from Example 11), 440 g of acetic acid, 100 g of concen-trated hydrochloric acid (37 %) and sufficient deionised water (in this specific case: 333 g) are added to produce a total of 2000 g of reaction solution. The mixture is stirred for 20 hours at 20°C. The change in the acetate content can be ascertained by titration of the acetic acid.
Isolation can be carried out by means of ultrafiltration: the reaction mixture is cooled to 15°C and adjusted to pH 3.6 with aqueous NaOH (5 %). The polymer solution is filtered by way of a 0.45 ltm filter and purified by means of ultrafiltration. The ultrafiltration is carried out using a 1-KD-Omega membrane produced by Filtron. Ultrafiltration is carried out to a residual sodium chloride content of 0.004 %. Before the purification is complete, the solution is adjusted to pH 7 with O.1N sodium hydroxide solution.
Concentration yields 1995 g of a 14.54 % polymer solution (92 % of theory); N-content (Kjendahl deter-mination) = 0.683 %, acetate content (ascertained by hydrolysis) = 2.34 meq/g, inherent viscosity: 0.310, double bonds: 0.5 meq/g (ascertained by microhydrogenation), free hydroxy groups (ascertained by reacetylation): 15.3 meq/g, GPC analysis (in water):
Mw=19 101, Mn=7 522, Mw/Mn=2.54.
The isolation can also be carried out by means of precipitation: the reaction mixture is adjusted to pH 3.6 with triethylamine and precipitated in acetone in a ratio of 1:10. The precipitate is separated off, dispersed twice with ethanol and once with acetone, and dried.
The product so obtained has the same properties as the product obtained by ultrafiltration.
Example 14: General preparative method for the reaction of PVA with acetals or aldehydes for the preparation of reaction products having a low acetate content.
300 g of PVA (for example Moviol Hoechst 4-88) are placed in a 2-litre double jacket reactor having a stirrer and thermometer, 800 g of deionised water are added and the mixture is heated to 95°C with stirring. After one hour, everything has dissolved to produce a clear solution which is cooled to 20°C. 27 g (0.155 mol) of methacrylamido-acetaldehyde dimethyl acetal (from Example 11), 200 g of concentrated hydrochloric acid (37 %) and sufficient deionised water (in this specific case: 673 g) are added to produce a total of 2000 g of reaction solution. The mixture is stirred at 20°C.
After 20 hours, a sample of the reaction solution is titrated with sodium hydroxide and the degree of hydrolysis of the PVA is ascertained: HCl = 1.034 meq/g, acetic acid = 0.265 meq/g corresponding to 3.5 mol % residual acetate. The reaction mixture is stirred for a further 2 hours at 25°C and titrated again. HCl = 1.034 meq/g, acetic acid =
0.277 meq/g, corres-ponding to 2.93 mol % residual acetate.
The isolation can be carried out by means of ultrafiltration: the reaction mixture is cooled to 15°C and adjusted to pH 7 with aqueous NaOH (5 %). The polymer solution is filtered by way of a 0.45 ~m filter and purified by means of ultrafiltration. The ultrafiltration is carried out using a 1-KD-Omega membrane produced by Filtron. Ultrafiltration is carried out to a residual sodium chloride content of 0.002 %. 1800 g of a 14.02 %
polymer solution (86 % of theory) are obtained; N-content (Kjendahl determination) =
0.741 %, acetate content (after titration) = 0.605 meq/g corresponding to 2.91 mol %, inherent viscosity: 0.327, double bonds: 0.61 meq/g (ascertained by microhydrogenation), free hydroxy groups (ascertained by reacetylation): 18.13 meq/g, GPC analysis (in water):
Mw = 22 007, Mn = 9 743, Mw/Mn = 2.26.
The isolation can also be carried out by means of precipitation: the reaction mixture is adjusted to pH 3.6 with triethylamine and precipitated in acetone in a ratio of 1:10. The precipitate is separated off, dispersed twice with ethanol and once with acetone, and dried.
The product so obtained is comparable with that obtained by ultrafiltration.
Example 15: Manufacture of contact lenses 0.3 % (based on polymer content) of the photoinitiator Irgacure 2959 is added to a 30 %
solution of the polymers listed below. The solutions are irradiated for 6 seconds in a trans-parent contact lens mould of polypropylene using a 200 W OrieIT"' UV lamp (150 mW/cm2).
The lenses are removed from the mould. They are transparent and have the properries listed below.
Examples 15a) to 15j): reaction products of PVA (4-88) Moviol Hoechst, 12 mol %
residual acetate, Mw = 19 115, Mn = 7887, Mw/Mn = 2.43, inherent viscosity =
0.35$, in accordance with the preparative method of Example 13 or 14, isolation by ultrafiltration:
15 a): 30 g of acetal from Example 11, preparative method according to Example 13, acetic acid addition: 700 g, inherent viscosity: 0.278, prepolymer data (sol): N content: 1.34 %, acetal content: 0.96 meq/g, acetate content: 19 mol %, Mw: 17 412, Mn: 6273, Mw/Mn: 2.77, solids content: 30 % in the sol state results in 38.4 % in the gel state.
15 b): 24 g of acetal from Example 11, preparative method according to Example 13, acetic acid addition: 300 g, inherent viscosity: 0.329, prepolymer data (sol): N content: 0.64 %, aceta.l content: 0.45 meq/g, acetate content: 9 mol %, solids content: 30 % in the sol state results in 29.5 % in the gel state.
15 c): 24 g of acetal from Example 11, preparative method according to Example 13, acetic acid addition: 700 g, inherent viscosity: 0.331, prepolymer data (sol): N content: 0.58 %, acetal content: 0.42 meq/g, acetate content: 17.5 mol %, Mw: 18 861, Mn: 8051, Mw/Mn: 2.34, solids content: 30 % in the sol state results in 27.6 % in the gel state.
15 d): 30 g of acetal from Example 11, preparative method according to Example 13, acetic acid addition: 500 g, inherent viscosity: 0.327, prepolymer data (sol): N content: 0.753 %, acetal content: 0.54 meq/g, acetate content: 12.5 mol %, Mw: 19 463, Mn: 8064, Mw/Mn: 2.41, solids content: 30 % in the sol state results in 30.0 % in the gel state.
15 e): 56 g of acetal from Example 1 l, preparative method according to Example 13, acetic acid addition: 1000 g, prepolymer data (sol): N content: 1.208 %, acetal content: 0.86 meq/g, acetate content: 26 mol %, solids content: 30 % in the sol state results in 36.7 % in the gel state.
15 f): 24 g of acetal from Example 11, preparative method according to Example 14, no acetic acid addition, inherent viscosity: 0.321, prepolymer data (sol): N content: 0.659 %, acetal content: 0.46 meq/g, acetate content: 5.9 mol %, Mw: 27 121, Mn: 6490, Mw/Mn: 4.18, solids content: 30 % in the sol state results in 30.0 % in the gel state.
15 g): 48 g of acetal from Example 11, preparative method according to Example 14, no acetic acid addition, prepolymer data (sol): N content: 1.23 %, acetal content: 0.88 meq/g, acetate content: 6.6 mol %, Mw: 18 833, Mn: 7047, Mw/Mn: 2.66, solids content: 30 % in the sol state results in 36.7 % in the gel state.
15 h): 27 g of acetal from Example 11, preparative method according to Example 14, no acetic acid addition, inherent viscosity: 0.31, prepolymer data (sol): N content: 0.638 %, acetal content: 0.53 meq/g, acetate content: 2.9 mol %, Mw: 19 101, Mn: 7522, Mw/Mn: 2.54, solids content: 30 % in the sol state results in 30.0 % in the gel state.
15 i): 31 g of acetal from Example 12, preparative method according to Example 14, no acetic acid addition, prepolymer data (sol): N content: 1.41 %, acetal content: 1.00 meq/g, acetate content: 6.2 mol %, solids content: 30 % in the sol state results in 37.0 % in the gel state.
15 j): 23 g of acetal from Example 12, preparative method according to Example 14, no acetic acid addition, inherent viscosity: 0.352, prepolymer data (sol): N content: 0.62 %, acetal content: 0.44 meq/g, acetate content: 5.8 mol %.
Examples 15 k) to 151): Reaction products of PVA (8-88) Moviol Hoechst, 12 mol %
residual acetate, Mw = 49 000, Mn = 19 600, Mw/Mn = 2.5, inherent viscosity =
0.546, according to the preparative method of Example 13, isolation by ultraflltration:
15 k): 53 g of acetal from Example 11, acetic acid addition: 400 g, prepolymer data (sol): N content: 1.31 %, acetal content: 0.94 meq/g, acetate content: 8.9 mol %, 15 1): 30 g of acetal from Example 11, acetic acid addition: 490 g, inherent viscosity:
0.495, prepolymer data (sol): N content: 0.747 %, acetal content: 0.54 meq/g, acetate content: 13.6 mol %, Mw: 44 334, Mn: 17 293, Mw/Mn: 2.56, solids content: 30 %~in the sol state results in 30.5 % in the gel state.
Within the scope of this invention, the term "lower" used in connection with radicals and compounds denotes radicals or compounds having up to 7 carbon atoms, preferably up to 4 carbon atoms, unless defined otherwise.
Lower alkyl has especially up to 7 carbon atoms, preferably up to 4 carbon atoms, and is, for example, methyl, ethyl, propyl, butyl or tcrt-butyl.
Lower alkoxy leas especially up to 7 carbon atoms, preferably up to 4 carbon atoms, and is, for example, mellloxy, etlloxy, propoxy, butoxy or tort-butoxy. _ 'hhe oleClnically unsaturated copolymerisable radical R3 having from 2 to 24 carbon atoms is preferably alkenyl having from 2 to 24 carbon atoms, especially alkcnyl having from 2 to S Carbon atUrllS and especially preferably alkenyl having from 2 to 4 carbon atoms, for cxarnplc etllcnyl, 2-prol~cnyl, 3-Ilropcnyl, 2-butcrryl, Ilcxcnyl, ocacnyl or dodcccnyl. l~Irc rncanings elllerlyl and 2-propenyl arc preferred, so that the group -CO-R3 is the acyl radical of acrylic or mctflacrylic acid.
'the divalent group -R'~-NI-i-CO-O- is pr~csent wllcn q is one and absent when q is zero.
1'repolymcrs in which q is zero are preferred.
'1'he divalent group -CO-NI-i-(R4-NI-I-CO-O)q-RS-O- is present when p is one and absent when p is zero. I'repolymers in which p is zero are preferred.
In pI-epUlynlCIS 111 Wl1IC11 p is ogle the index q is preferably zero.
Prepolymers in which p is one, the index q is zero and RS is lower alkylenc arc especially preferred.
~prefcrredprcpolynler_ is therefore especially a derivative of a polyvinyl alcohol having a molecular weight of at least about 2000 that, based on the number of hydroxy groups of the polyvinyl alcohol, comprises from approximately 0.5 to approxinlatcly 80 °lo of units of formula I1I in which R is lower alkylene having up to G
carbon atoms, p is zero and R~ is alkcnyl having from 2 to 8 ctu-bon acorns.
~e~
-G-A further preferred prepolymer, is therefore especially a deriv-alive of a polyvinyl alcohol having a molecular weight of at least about 2000 that, based Uil tllC IIUITIbcr of leydroxy groups of tile polyvinyl alcullol, colnpriscs from approxilnately U.5 to approximately 80 % of units of formula 1II in which R is lower alkylcne having up to G carbon atoms, p is one, d is zero, RS is lower alkylene leaving from 2 to G ctu-bon atoms and R3 is alkcllyl leaving froln 2 to 8 carbon atoms.
A further preferred prepolymcr, is therefore especial ly a deriv-alive of a polyvinyl alcohol having a molecular weight of at least about 2000 that, based on tile number of hydroxy groups of tile polyvinyl alcohol, comprises from approxilnatcly U.5 to approxinlatcly 8U % of units of formula Ill in wllicle R is lower alkylele leaving up to G carbon atoms, p 1S UI1C, q is one, R't is lower alkylene leaving from 2 to G carbon atoms, pleenylene, unsubstiwted or substituted by lower alkyl, cycloleexylenc or cyclo-hexylcne-lower alkylcne, unsubstitutcd or substituted by lower alkyl, phenylcne-lower alkylenc, lower alkylcnc-phenylenc or phenylenc-lower alkylcnc-phenylenc, RS
is lower alkylcne leaving from 2 to G carbon atoms and R3 is alkenyl having from 2 to 8 carbon atUteeS.
'flee prcpolyrncrs are preferably derivat ives of polyvinyl alcohol leaving a molecular weight of at least about 2000 that, based on the number of hydroxy groups of the polyvinyl alcohol, comprises from approximately 0.5 to approximately 8U
%, especially MpprUX1111atCly fr0111 1 to SU %, preferably approximately from 1 to 25 %, preferably aleproxineately from 2 to 15 % and especially preferably approximately front 3 to lo %, of units of formula III. I'repolylners according to tile invention which arc Ilrovided for tile Illaleufacture of contact Icllses comprise, based on tile number of Ilydroxy groups of the polyvinyl alcohol, especially from approximately 0.5 to approximately 25 %, especially approximately from 1 to 15 % and especially preferably approximately from 2 to 12 %, of units of forlnula III.
Polyvinyl alcohols that can be derivatised in accordance with the invention preferably leave a molecular weight of at least 10 UUU. As an upper limit tile polyvinyl alcollols may have a neoleculalr weight of up to 1 UUO UOU. Preferably, the polyvinyl alcollols (lave a molecular wciglet of up to 300 UUU, especially up to approximately IUU UUU and especially preferably up to approximately SU UUU.
-7_ Polyvinyl alcohols suitable in accordance with the invention usually have a poly(2-hydroxy)ethylene structure. The polyvinyl alcohols derivatised in accordance with the invention may, however, also comprise hydroxy groups in the form of 1,2-glycols, such as copolymer units of 1,2-dihydroxyethylene, as may be obtained, for example, by the alkaline hydrolysis of vinyl acetate/vinylene carbonate copolymers.
In addition, the polyvinyl alcohols derivatised in accordance with the invention may also comprise small proportions, for example up to 20 %, preferably up to 5 %, of copolymer units of ethylene, propylene, acrylamide, methacrylamide, dimethacrylamide, hydroxy-ethyl methacrylate, methyl methacrylate, methyl acrylate, ethyl acrylate, vinylpyrrolidone, hydroxyethyl acrylate, allyl alcohol, styrene or similar customarily used comonomers.
Commercially available polyvinyl alcohols may be used, such as, for example, Vinol~
107 produced by Air Products (MW = 22 000 to 31 000, 98 - 98.8 % hydrolysed), Polysciences 4397 (MW = 25 000, 98.5 % hydrolysed), BF 14 produced by Chan Chun, Elvanol~ 90 - SO produced by DuPont, UF-120 produced by Unitika, Moviol~ 4-88, 10-98 and 20-98 produced by Hoechst. Other manufacturers are, for example, Nippon Gohsei (Gohsenol~), Monsanto (Gelvatol~), Wacker (Polyviol~) and the Japanese manufacturers Kuraray, Denki and Shin-Etsu.
As already mentioned, it is also possible to use copolymers of hydrolysed vinyl acetate, which are obtainable, for example, in the form of hydrolysed ethylene/vinyl acetate (EVA), or vinyl chloride/vinyl acetate, N-vinylpyrrolidone/vinyl acetate and malefic acid anhydride/vinyl acetate.
Polyvinyl alcohol is usually prepared by hydrolysis of the corresponding homopolymeric polyvinyl acetate. In a preferred embodiment, the polyvinyl alcohol derivatised in accordance with the invention comprises less than 50 % of polyvinyl acetate units, especially less than 20 % of polyvinyl acetate units. Preferred amounts of residual acetate units in the polyvinyl alcohol derivatised in accordance with the invention, based on the sum of vinyl alcohol units and acetate units, are approximately from 3 to 20 %, preferably approximately from 5 to 16 % and especially approximately from 10 to 14 %.
The compounds comprising units of formula III may be prepared in a manner known her se. For example, a polyvinyl alcohol having a molecular weight of at least about 2000 that comprises units of formula IV
_g_ -CH(OH)-CH2- (IV) may be reacted with approximately from 0.5 to 80 %, based on the number of hydroxy groups of the compound of formula IV, of a compound of formula (V) R' R"
O~ CH ~O
R~
N /
[CO-NH-(R4-NH-CO-O)q-RS-O]P-CO-R3 in which R' and R" are each independently hydrogen, lower alkyl or lower alkanoyl, such as acetyl or propionyl, and the other variables are as defined for formula III, especially in an acidic medium.
Alternatively, a polyvinyl alcohol having a molecular weight of at least about 2000 that comprises units of formula IV may be reacted with a compound of formula VI
R' R"
O~ CH ~O (VI) R~
N /
~W
in which the variables are as defined for the compound of formula V, especially under acidic conditions, and the cyclic acetal obtainable in that manner may then be reacted with a compound of formula VII
OCN-(R4-NH-CO-O)q RS-O-CO-R3 (VII) in which the variables are as defined for the compound of formula V.
Alternatively, the product obtainable as described above from a compound of formula IV
and a compound of formula VI may be reacted with a compound of formula (VIII) X-CO-R3 (VIB) in which R3 is, for example, alkenyl having from 2 to 8 carbon atoms and X is a reactive group, for example etherified or esterified hydroxy, for example halogen, especially chlorine.
Compounds of formula V in which p is zero are known, for example, from EP 201 693.
Compounds of formula VI are also described therein. Compounds of formula VII
are known her se, or can be prepared in a manner known Qer se. An example of a compound of formula VII in which q is zero is isocyanatoethyl methacrylate. An example of a compound of formula VII in which q is one is the reaction product of isophorone diiso-cyanate with 0.5 equivalent of hydroxyethyl methacrylate. Compounds of formula VIII are known her se; a typical representative is methacryloyl chloride. Compounds of formula V
in which p and/or q are 1 can be prepared in a manner known ~ se from the above-mentioned compounds, for example by reaction of a compound of formula VI with iso-cyanatoethyl methacrylate or by reaction of a compound of formula VI with isophorone diisocyanate which has previously been terminated with 0.5 equivalent of hydroxyethyl methacrylate.
Surprisingly the prepolymers of formulae I and III are extraordinarily stable.
This is unexpected for the person skilled in the an because, for example, higher-functional acrylates usually have to be stabilised. If such compounds are not stabilised then rapid polymerisation usually occurs. Spontaneous crosslinking by homopolymerisation does not occur, however, with the prepolymers of the invention. The prepolymers of formulae I and III can furthermore be purified in a manner known her se, for example by precipitation with acetone, dialysis or ultrafrltration, ultrafiltration being especially preferred. By means of that purification process the prepolymers of formulae I and III can be obtained in extremely pure form, for example in the form of concentrated aqueous solutions that are free, or at least substantially free, from reaction products, such as salts, and from starting materials, such as, for example, compounds of formula V or other non-polymeric constituents.
- lU
The prefen~ed purification process for the prepolymers of the invention, ultrafiltration, cm be carried out in a nllulner known ~ se. It is possible for the ultrafiltration to be carried out repeatedly, for example from two to ten times. Alternatively, the ultrafiltration call be carried out CUIItIrIUUUSIy until tllc selected degree of purity is attained.
'hhc selected degree of purity can in principle be as higtl as desired. A suitable measure for the degree of purity is, for example, the sodium chloride content of the solution, which can be determined simply in known manner.
'1 he prepolymers of formulae I and III according to the invention are on the other hand crosslirlkable in as extremely effective and CUI1LIUIICd ItlaIlIICI, especially by photocross-linkirlg.
The present invention is therefore also directed to a polymer that can be obtained by photocrosslinking a prepolymer comprising units of formula I or III in the absence or presence of all addltlonal vinylic comonomer. 'Those polymers are water-insoluble.
In the case of photocrosslinking, it is appropriate to add a photoinitiator which cal initiate radical crosslinking. Cxamplcs thereof are familiar to the person skilled in the al-t and suitable photoinitiators lilac may be mentioned specifically are bcIlZUlrl IIICtllyl etfler, 1-llydroxycyclollexylpfrenyl ketone, Darocurc~1173 or Irgacurc types. 'I'lle crosslinking cars then be triggered by actinic radiation, such as, for example, UV light, or ionising radiation, such as, for cxa rnplc, gamma radiation or X-radiation.
The photopolymerisatiol is suitably carried out in a solvent. A suitable solvent is in principle any solvent that dissolves polyvinyl alcohol and the vinylic comonomers optionally used in addition, for example water, alcohols, such as lower alkalols, for example ctllallol or methanol, also carboxylic acid amides, such as dimethylformamide, or dilnethyl sulfoxide, and also a mixture of suitable solvents, such as, for example, a mixture of water with an alcohol, such as, for example, a water/ethallol or a water/-Illctha1101 mixture.
'the photocrosslinking is carried out preferably directly from an aqueous solution of the prepolymers according to the invention, which can be obtained by the preferred puriClca-tioll step, ultraGltration, where appropriate after the addition of an additional vinylic comonomer. I~or example, an approximately I5 to 4U % aqueous solution can be plloto-*Trade-mark crosslinked.
The process for the preparation of the polymers of the invention may comprise, for example, photocrosslinking a prepolymer comprising units of formula I or III, especially in substantially pure form, that is to say, for example, after single or repeated ultra-filtration, preferably in solution, especially in aqueous solution, in the absence or presence of an additional vinylic comonomer.
The vinylic comonomer which, in accordance with the invention, may be used in addition in the photocrosslinking, may be hydrophilic or hydrophobic, or a mixture of a hydro-phobic and a hydrophilic vinylic monomer. Suitable vinylic monomers include especially those customarily used in the manufacture of contact lenses. A hydrophilic vinylic monomer denotes a monomer that typically yields as homopolymer a polymer that is water-soluble or can absorb at least 10 % by weight of water. Analogously, a hydrophobic vinylic monomer denotes a monomer that typically yields as homopolymer a polymer that is water-insoluble and can absorb less than 10 % by weight of water.
Generally, approximately from 0.01 to 80 units of a typical vinylic comonomer react per unit of formula I or III.
If a vinylic comonomer is used, the crosslinked polymers according to the invention preferably comprise approximately from 1 to 15 %, especially preferably approximately from 3 to 8 %, of units of formula I or III, based on the number of hydroxy groups of the polyvinyl alcohol, which are reacted with approximately from 0.1 to 80 units of the vinylic monomer.
The proportion of the vinylic comonomers, if used, is preferably from 0.5 to 80 units per unit of formula I, especially from 1 to 30 units per unit of formula I, and especially preferably from 5 to 20 units per unit of formula I.
It is also preferable to use a hydrophobic vinylic comonomer or a mixture of a hydro-phobic vinylic comonomer with a hydrophilic vinylic comonomer, the mixture comprising at least 50 % by weight of a hydrophobic vinylic comonomer. In that manner the mechanical properties of the polymer can be improved without the water content falling substantially. In principle, however, both conventional hydrophobic vinylic comonomers and conventional hydrophilic vinylic comonomers are suitable for the copolymerisation with polyvinyl alcohol comprising groups of formula I.
Suitable hydrophobic vinylic comonomers include, without the list being exhaustive, Ct-Ctgalkyl acrylates and methacrylates, C3-Ctgalkyl acrylamides and methacrylamides, acrylonitrile, methacrylonitrile, vinyl-C1-Ctgalkanoates, C2-Cl8alkenes, C2-Ctghalo-alkenes, styrene, Ct-C6alkylstyrene, vinyl alkyl ethers, in which the alkyl moiety contains from 1 to 6 carbon atoms, C2-Ctoperfluoroalkyl acrylates and methacrylates or corres-pondingly partially fluorinated acrylates and methacrylates, C3-Ctzperfluoroalkyl-ethyl-thiocarbonylaminoethyl acrylates and methacrylates, acryloxy- and methacryloxy-alkylsil-oxanes, N-vinylcarbazole, Cl-Cl2alkyl esters of malefic acid, fumaric acid, itaconic acid, mesaconic acid and the like. Cl-C4alkyl esters of vinylically unsaturated carboxylic acids having from 3 to 5 carbon atoms or vinyl esters of carboxylic acids having up to S carbon atoms, for example, are preferred.
Examples of suitable hydrophobic vinylic comonomers include methyl acrylate, ethyl acrylate, propyl acrylate, isopropyl acrylate, cyclohexyl acrylate, 2-ethylhexyl acrylate, methyl methacrylate, ethyl methacrylate, propyl methacrylate, vinyl acetate, vinyl prop-ionate, vinyl butyrate, vinyl valerate, styrene, chloroprene, vinyl chloride, vinylidene chloride, acrylonitrile, 1-butene, butadiene, methacrylonitrile, vinyltoluene, vinyl ethyl ether, perfluorohexylethylthiocarbonylaminoethyl methacrylate, isobornyl methacrylate, trifluoroethyl methacrylate, hexafluoroisopropyl methacrylate, hexafluorobutyl meth-acrylate, tris-trimethylsilyloxy-silyl-propyl methacrylate, 3-methacryloxypropylpenta-methyldisiloxane and bis(methacryloxypropyl)tetramethyldisiloxane.
Suitable hydrophilic vinylic comonomers include, without the list being exhaustive, hydroxy-substituted lower alkyl acrylates and methacrylates, acrylamide, methacrylamide, lower alkyl acrylamides and methacrylamides, ethoxylated acrylates and methacrylates, hydroxy-substituted lower alkyl acrylamides and methacrylamides, hydroxy-substituted lower alkyl vinyl ethers, sodium ethylenesulfonate, sodium styrenesulfonate, 2-acryl-amido-2-methylpropanesulfonic acid, N-vinylpyrrole, N-vinylsuccinimide, N-vinylpyrrol-idone, 2- or 4-vinylpyridine, acrylic acid, methacrylic acid, amino- (the term "amino" also including quaternary ammonium), mono-lower alkylamino- or di-lower alkylamino-lower alkyl acrylates and methacrylates, allyl alcohol and the like. Hydroxy-substituted C2-C4-alkyl(meth)acrylates, five- to seven-membered N-vinyl lactams, N,N-di-Ct-C4alkyl-(meth)acrylamides and vinylically unsaturated carboxylic acids having a total of from 3 to carbon atoms, for example, are preferred.
Examples of suitable hydrophilic vinylic comonomers include hydroxyethyl methacrylate, hydroxyethyl acrylate, acrylamide, methacrylamide, dimethylacrylamide, allyl alcohol, vinylpyridine, vinylpyrrolidone, glycerol methacrylate, N-(1,1-dimethyl-3-oxobutyl)-acrylamide, and the like.
Preferred hydrophobic vinylic comonomers are methyl methacrylate and vinyl acetate.
Preferred hydrophilic vinylic comonomers are 2-hydroxyethyl methacrylate, N-vinyl-pyrrolidone and acrylamide.
The prepolymers according to the invention can be processed in a manner known her se into mouldings, especially contact lenses, for example by carrying out the photocrosslinldng of the prepolymers according to the invention in a suitable contact lens mould. The invention is therefore also directed to mouldings that consist substantially of a polymer according to the invention. Further examples of mouldings according to the invention, besides contact lenses, are biomedical or especially ophthalmic mouldings, for example intraocular lenses, eye bandages, mouldings that can be used in surgery, such as heart valves, artificial arteries or the like, and also films or membranes, for example membranes for diffusion control, photostructurizable films for information storage, or photoresist materials, for example membranes or mouldings for etch resist or screen printing resist.
A special embodiment of the invention is directed to contact lenses that comprise a polymer according to the invention or consist substantially or wholly of a polymer according to the invention. Such contact lenses have a wide range of unusual and extremely advantageous properties, which include, for example, their excellent compat-ibility with the human cornea, which is based on a balanced relationship of water content, oxygen permeability and mechanical properties. The contact lenses according to the invention furthermore exhibit a high degree of dimensional stability. No changes in shape are detected even after autoclaving at, for example, about 120°C.
Attention may also be drawn to the fact that the contact lenses according to the invention, which means especially those comprising a polymer based on a prepolymer comprising units of formula I, can be produced in a very simple and efficient manner compared with the state of the art. This is as a result of several factors. First, the starting materials can be obtained or produced at a favourable cost. Secondly, there is the advantage that the prepolymers are surprisingly stable, so that they can be subjected to a high degree of purification. It is therefore possible to use for the crosslinking a prepolymer that requires practically no subsequent purification, such as especially a complicated extraction of unpolymerised constituents. Also, the polymerisation can be carried out in aqueous solution, so that a subsequent hydration step is not necessary. Finally, the photopolymerisation occurs within a short period, so that the process for manufacturing the contact lenses according to the invention can be organised to be extremely economical from that point of view also.
All of the advantages mentioned above naturally apply not only to contact lenses but also to other mouldings according to the invention. Taking into account all the various advant-ageous aspects in the manufacture of the mouldings~according to the invention it can be seen that the mouldings according to the invention are especially suitable as mass-produced articles, such as, for example, contact lenses that are worn for a short time and then replaced by new lenses.
The present invention also relates to the manufacture of mouldings according to the invention, especially contact lenses according to the invention. In the following, those processes are illustrated using the example of contact lenses, but the processes can, however, also be used for other mouldings according to the invention.
The contact lenses according to the invention can be manufactured, for example, in a manner known her se, for example in a conventional "spin-casting mould", as described, for example, in US-A-3 408 429, or by the so-called Full-Mould process in a static mould, as described, for example, in US-A-4 347 198.
It has been ascertained in accordance with the invention that the process described above with reference to prepolymers comprising units of formula I can be applied generally. The Rresent invention therefore relates to a novel process for the manufacture of polymeric mouldings, especially contact lenses, in which a water-soluble prepolymer comprising crosslinkable groups is crosslinked in solution, and to mouldings, especially contact lenses, obtainable in accordance with that process. The mouldings obtainable in that manner by crosslinking are water-insoluble but are swellable in water.
In detail, the process for the manufacture of mouldings, especially contact lenses, comprises the following steps:
a) the preparation of a substantially aqueous solution of a water-soluble prepolymer that comprises crosslinkable groups, b) the introduction of the solution obtained into a mould, c) the triggering of the crosslinking, d) opening of the mould such that the moulding can be removed from the mould.
Unless expressly excluded hereinafter, the detailed explanations and preferences disclosed hereinbefore in connection with prepolymers comprising units of formula I, and also the detailed explanations and preferences disclosed in connection with the processes for the production of polymers and mouldings, such as, especially, contact lenses, from those pre-polymers, apply also to the process comprising steps a), b), c) and d) described in the above paragraph. This statement applies to all cases in which the detailed explanations and preferences in connection with prepolymers comprising units of formula I can sensibly be applied to the process described in the above paragraph.
The decisive criteria determining the suitability of a prepolymer for use in the process according to the invention are that the prepolymer is soluble in water and that it comprises crosslinkable groups.
The preparation of a substantially aqueous solution of a water-soluble prepolymer that comprises crosslinkable groups can be carried out in a manner known ~ se, for example by synthesis of the prepolymer in a substantially aqueous solution or by isolation of the prepolymer for example in pure form, which means free from undesired constituents, and dissolution thereof in a substantially aqueous medium.
In accordance with the invention, the criterion that the prepolymer is soluble in water denotes in particular that the prepolymer is soluble in a concentration of approximately from 3 to 90 % by weight, preferably approximately from 5 to 60 % by weight, especially approximately from 10 to 60 % by weight, in a substantially aqueous solution.
Insofar as it is possible in an individual case, prepolymer concentrations of more than 90 %
are also included in accordance with the invention. Especially prefert-ed concentrations of the prepolymer in solution are from approximately 15 to approximately 50 % by weight, especially from approximately 15 to approximately 40 % by weight, for example from approximately 25 % to approximately 40 % by weight.
Within the scope of this invention, substantially aqueous solutions of the prepolymer comprise especially solutions of the prepolymer in water, in aqueous salt solutions, especially in aqueous salt solutions that have an osmolarity of approximately from 200 to 450 milliosmol per 1000 ml (unit: mOsm/1), preferably an osmolarity of approximately from 250 to 350 mOsm/l, especially approximately 300 mOsm/1, or in mixtures of water or aqueous salt solutions with physiologically tolerable polar organic solvents, such as, for example, glycerol. Solutions of the prepolymer in water or in aqueous salt solutions are preferred.
The aqueous salt solutions are advantageously solutions of physiologically tolerable salts, such as buffer salts customary in the field of contact lens care, for example phosphate salts, or isotonising agents customary in the field of contact lens care, such as, especially, alkali halides, for example sodium chloride, or solutions of mixtures thereof.
An example of an especially suitable salt solution is an artificial, preferably buffered, lacrimal fluid that in respect of pH value and osmolarity is adapted to natural lacrimal fluid, for example a sodium chloride solution that is unbuffered or that is preferably buffered, for example, by phosphate buffer, and that has an osmolarity that corresponds to the osmolarity of human laclimal fluid.
The substantially aqueous solution of the prepolymer defined hereinbefore is preferably a pure solution which means a solution which is free or essentially free from undesired constituents. Especially preferred examples of such solutions are a solution of the prepolymer in pure water or in an artificial lacrimal fluid, as defined hereinbefore.
The viscosity of the solution of the prepolymer in the substantially aqueous solution is, within wide limits, not critical, but the solution should preferably be a flowable solution that can be deformed strain-free.
The molecular weight of the prepolymer is also, within wide limits, not critical.
Preferably, however, the prepolymer has a molecular weight of from approximately 000 to approximately 200 000.
The prepolymer used in accordance with the invention must furthermore comprise cross-linkable groups. "Crosslinkable groups" denotes customary crosslinkable groups well-known to the person skilled in the art, such as, for example, photocrosslinkable or thermally crosslinkable groups. Crosslinkable groups such as those already proposed for the preparation of contact lens materials are especially suitable. Those include especially, but not exclusively, groups comprising carbon-carbon double bonds. To demonstrate the large variety of suitable crosslinkable groups, there are mentioned here, merely by way of example, the following crosslinking mechanisms: radical polymerisation, 2+2 cyclo-addition, Diels-Alder reaction, ROMP (Ring Opening Metathesis Polymerisation), vulcan-isation, cationic crosslinking and epoxy hardening.
Suitable water-soluble prepolymers that comprise crosslinkable groups are, for example, compounds comprising units of formula I. It is also possible, however, to use in the process other water-soluble prepolymers that comprise a polymeric backbone and also crosslinkable groups.
Suitable polymeric backbones include, besides polyvinyl alcohol, materials such as those already proposed in some cases as contact lens materials, for example polymeric diols other than PVA, polymers comprising saccharides, polymers comprising vinylpyrrolidone, polymers comprising alkyl(meth)acrylates, polymers comprising alkyl(meth)acrylates that have been substituted by hydrophilic groups, such as by hydroxy, carboxy or by amino, polyalkylene glycols, or copolymers or mixtures thereof.
The prepolymer used in accordance with the invention preferably comprises crosslinkable groups in an amount of from approximately 0.5 to approximately 80 %
equivalents, based on the equivalents of monomers that form the polymeric backbone, especially approx-imately from 1 to 50 %, preferably approximately from 1 to 25 %, preferably approx-imately from 2 to 15 % and especially preferably approximately from 3 to 10 %.
Also especially preferred are amounts of crosslinkable groups of from approximately 0.5 to approximately 25 % equivalents, especially approximately from 1 to 15 % and especially preferably approximately from 2 to 12 %, based on the equivalents of monomers that form the polymeric backbone.
As already mentioned, an essential criterion for the suitability of a prepolymer for the process according to the invention is that it is a crosslinkable prepolymer, but the pre-polymer is uncrosslinked, or at least substantially uncrosslinked, so that it is water-soluble.
- 1g -In addition, the prepolymer is advantageously stable in the uncrosslinked state, so that it can be subjected to purification as described hereinbefore in connection with compounds comprising units of formula I. The prepolymers are preferably used in form of a pure solution in the process according to the invention. The prepolymers can be converted into the form of a pure solution for example in the manner disclosed hereinafter.
Preferably, the prepolymers used in the process according to the invention can be purified in a manner known ~ se, for example by precipitation with organic solvents, such as acetone, filtration and washing, extraction in a suitable solvent, dialysis or ultrafiltration, ultrafiltration being especially preferred. By means of that purification process the pre-polymers can be obtained in extremely pure form, for example in the form of concentrated aqueous solutions that are free, or at least substantially free, from reaction products, such as salts, and from starting materials, such as, for example, non-polymeric constituents.
The preferred purification process for the prepolymers used in the process according to the invention, ultraftltration, can be carried out in a manner known her se. It is possible for the ultrafiltrarion to be carried out repeatedly, for example from two to ten times.
Alternatively, the ultrafiltration can be carried out continuously until the selected degree of purity is attained. The selected degree of purity can in principle be as high as desired. A
suitable measure for the degree of purity is, for example, the sodium chloride content of the solution, which can be determined simply in known manner.
In a preferred embodiment of the process according to the invention there is prepared in step a) and further used in the process a substantially aqueous solution of the prepolymer that is substantially free from undesired constituents, such as, for example, free from monomeric, oligomeric or polymeric starting compounds used for the preparation of the prepolymer, and/or free from secondary products formed during the preparation of the prepolymer. The substantially aqueous solution is more preferably a pure aqueous solution or a solution in an artificial lacrimal fluid, as defined hereinbefore. It is also preferable to carry out the process according to the invention without the addition of a comonomer, for example a vinylic comonomer.
On the basis of one of the measures mentioned in the above paragraph, and especially on the basis of a combination of the measures mentioned in the above paragraph, the solution of the prepolymer used in the process according to the invention is one that comprises no, or substantially no, undesired constituents that would have to be extracted after a crosslinking operation. A particular feature of this preferred embodiment of the process according to the invention is therefore that the extraction of undesired constituents follow-ing crosslinking can be dispensed with.
The process according to the invention is therefore preferably carried out in such a manner that the substantially aqueous solution of the water-soluble prepolymer comprising cross-linkable groups is free or substantially free of undesired constituents, such as especially monomeric, oligomeric or polymeric starting compounds used for the preparation of the prepolymer, or secondary products that have formed during the preparation of the prepolymer, and/or that the solution is used without the addition of a comonomer, so that the extraction of any undesired constituents in the further course of the process can be dispensed with.
One additive that is added, where appropriate, to the solution of the prepolymer is an initiator for the crosslinking, should an initiator be required for crosslinking the cross-linkable groups. That may be the case especially if the crosslinking is carried out by photocrosslinking, which is preferred in the process according to the invention.
In the case of photocrosslinking, it is appropriate to add a photoinitiator which can initiate radical crosslinldng. Examples thereof are familiar to the person skilled in the art and suitable photoinitiators that may be mentioned specifically are benzoin methyl ether, 1-hydroxycyclohexylphenyl ketone, or a commercial product such as Darocure- or Irgacure types, e.g. Darocure 1173 or Irgacure 2959.
Methods that are known her se, such as, especially, conventional metering in, for example by dropwise introduction, may be used to introduce the resulting solution into a mould.
Suitable moulds are generally customary contact lens moulds as known in the state of the art. Thus, the contact lenses according to the invention can be manufactured, for example, in a manner known ~ se, for example in a conventional "spin-casting mould", as described, for example, in US-A-3 408 429, or by the so-called Full-Mould process in a static mould, as described, for example, in US-A-4 347 198. Appropriate moulds are made, for example, from polypropylene. Quartz, sapphire glass and metals, for example, are suitable materials for re-usable moulds.
The crosslinking can be triggered in the mould, for example by actinic radiation, such as, for example, UV light, or by ionising radiation, such as, for example, gamma radiation, electron radiation or X radiation. The crosslinking can where appropriate also be triggered thermally. Attention is drawn to the fact that the crosslinking can be carried out according to the invention in a very short time, for example in less than five minutes, preferably in less than one minute, especially in up to 30 seconds, especially preferably, as disclosed in the examples.
The opening of the mould such that the moulding can be removed from the mould can be carried out in a manner known per se. Whereas in processes that have been proposed in the state of the art it is usually necessary at that point for purification steps to follow, for example extraction, and also steps for the hydration of the resulting mouldings, especially contact lenses, such steps are not necessary in the process according to the invention.
Since the solution of the prepolymer preferably does not comprise any undesired low-molecular constituents, the crosslinked product, too, does not comprise any such constituents. Therefore subsequent extraction is not necessary. Since the crosslinking is carried out in a substantially aqueous solution, subsequent hydration is not necessary.
Those two advantages mean, inter alia, that a complicated after-treatment of the resulting mouldings, especially contact lenses, is dispensed with. The contact lenses obtainable in accordance with the process according to the invention are therefore, according to an advantageous embodiment, distinguished by the fact that they are suitable for their intended use without extraction. "Intended use" in this context means especially that the contact lenses can be used in the human eye. The contact lenses obtainable in accordance with the process according to the invention are, according to an advantageous embodi-ment, also distinguished by the fact that they are suitable for their intended use without hydration.
The process according to the invention is therefore outstandingly well suited to the economical manufacture of a large number of mouldings, such as contact lenses, in a short time. The contact lenses obtainable in accordance with the process according to the invention have inter alia the advantages over the contact lenses known from the state of the art that they can be used for their intended use without subsequent treatment steps, such as extraction or hydration.
In the following Examples, unless expressly stated otherwise amounts are amounts by weight, and temperatures are in degrees Celsius. The Examples are not intended to limit the invention in any way, for instance to the scope of the Examples.
Example la): Over a period of 4 hours, 104.5 parts of methacryloyl chloride dissolved in 105 parts of dichloromethane are added dropwise at a maximum of 15°C, while cooling with ice, to 105.14 pans of aminoacetaldehyde dimethylacetal and 101.2 parts of triethyl-amine in 200 parts of dichloromethane. When the reaction is complete, the dichloro-methane phase is washed with 200 parts of water then with 200 parts of 1N HCl solution, and then twice with 200 parts of water. After drying with anhydrous magnesium sulfate, the dichloromethane phase is concentrated by evaporation and stabilised with 0.1 % of 2,6-di-tert-butyl-p-cresol, based on the reaction product. After distillation at 90°C/10'3 mbar, 112 g of methacrylamidoacetaldehyde dimethylacetal are obtained in the form of a colourless liquid, boiling point 92°C/10-3 mbar (65 % yield).
Example 1b): 52.6 g of aminoacetaldehyde dimethylacetal are dissolved in 150 ml of deionised water and cooled to 5°C with ice. Subsequently, 50 ml of methacrylic acid chloride and 50 ml of 30 % sodium hydroxide solution are simultaneously so added over a period of 40 minutes that the pH value remains at 10 and the temperature does not exceed 20°C. When the addition is complete, the remaining content of aminoacetaldehyde dimethylacetal is determined as 0.18 % by gas chromatography. The amine is reacted fully by the further addition of 2.2 ml of methacrylic acid chloride and 2.0 ml of 30 % sodium hydroxide solution. The solution is then neutralised with 1 N hydrochloric acid (pH = 7).
The aqueous phase is extracted with 50 ml of petroleum ether and washed with water. The petroleum ether phase contains 3.4 g of secondary product. The aqueous phases are combined and yield 402.8 g of a 20.6 % solution of methacrylamidoacetaldehyde dimethylacetal. According to a gas chromatogram, the product is 98.2 %.
Example 2: 10 parts of polyvinyl alcohol having a molecular weight of 22 000 and a degree of hydrolysis of 97.5 - 99.5 % are dissolved in 90 parts of water, 2.5 parts of meth-acrylamidoacetaldehyde dimethylacetal are added and the mixture is acidified with parts of concentrated hydrochloric acid. The solution is stabilised with 0.02 parts of 2,6-di-tert-butyl-p-cresol. After stirring for 20 hours at room temperature, the solution is adjusted to pH 7 with 10 % sodium hydroxide solution and then ultrafiltered seven times using a 3kD membrane (ratio 1:3). After concentration, an 18.8 % aqueous solution of methacrylamidoacetaldehydo-1,3-acetal of polyvinyl alcohol having a viscosity of 2240 cP at 25°C is obtained.
Example 3: 10 parts of the solution of methacrylamidoacetaldehydo-1,3-acetal of polyvinyl alcohol obtained in accordance with Example 2 are photochemically crosslinked by adding 0.034 parts of Darocure 1173 (CIBA-GEIGY) thereto. The mixture is irradiated in the form of a 100 micron thick layer between two glass plates with 200 pulses of a 5000 watt irradiation device produced by Staub. A solid transparent film with a solids content of 31 % is obtained.
Example 4: 110 g of polyvinyl alcohol (Moviol 4-88, Hoechst) are dissolved at 90°C in 440 g of deionised water and cooled to 22°C. 100.15 g of a 20.6 %
aqueous solution of methacrylamidoacetaldehyde dimethylacetal, 38.5 g of concentrated hydrochloric acid (37 % p.a., Merck) and 44.7 g of deionised water are added thereto. The mixture is stirred at room temperature for 22 hours and then adjusted to pH 7.0 with a 5 % NaOH
solution.
The solution is diluted to 3 litres with deionised water, filtered and ultrafiltered using a 1-KD-Omega membrane produced by Filtron. After the three-fold specimen volume has permeated, the solution is concentrated. 660 g of a 17.9 % solution of the methacrylamido-acetaldehydo-1,3-acetal of polyvinyl alcohol having a viscosity of 210 cp are obtained.
The inherent viscosity of the polymer is 0.319. The nitrogen content is 0.96 %. According to NMR investigation, 11 mol % of the OH groups have been acetalised and 5 mol % of the OH groups acetylated. Concentration of the aqueous polymer solution under reduced pressure and with air draft yields a 30.8 % solution having a viscosity of 3699 cp.
Example 5: 66.6 g of deionised water, 3.3 g of monomeric 4-methacrylamidobutyr-aldehyde diethylacetal and 20.0 g of concentrated hydrochloric acid (37 %
p.a., Merck) are added to 133.3 g of a 15 % polyvinyl alcohol solution (Moviol 4-88, Hoechst) and the mixture is stirred at room temperature for 8 hours. The solution is then adjusted to pH 7 with 5 % sodium hydroxide solution. After ultrafiltration of the solution using a 3-KD-Omega membrane produced by Filtron, the sodium chloride content of the polymer solution being reduced from 2.07 % to 0.04 %, a 20 % polymer solution of the methacryl-amidobutyraldehydo-1,3-acetal of polyvinyl alcohol having a viscosity of 400 cp is obtained. The inherent viscosity of the polymer is 0.332. The nitrogen content is 0.41 %.
According to NMR investigation, 7.5 mol % of the OH groups are charged with acetal groups and 7.3 mol % of the OH groups are charged with acetate groups.
Example 6: 2.4 g (14.8 mmol) of aminobutyraldehyde diethylacetal (Fluka) and 20 g of concentrated hydrochloric acid (37 % p.a., Merck) are added to 200 g of a 10 %
polyvinyl alcohol solution (Moviol 4-88, Hoechst). The solution is stirred at room temperature for 48 hours and then neutralised with 10 % sodium hydroxide solution. The solution is diluted to 400 ml. 200 ml of the solution are further processed in accordance with Example 7. 0.85 g (8.1 mmol) of methacrylic acid chloride (Fluka) is added to the remaining 200 ml of the solution and the pH value is maintained at 10 with 2N
sodium hydroxide solution. After 30 minutes at room temperature, the pH is adjusted to 7.0 and the solution is purified analogously to Example 5 using a 3-KD-Omega membrane produced by Filiron. Concentration yields a 27.6 % polymer solution of the methacryl-amidobutyraldehydo-1,3-acetal of polyvinyl alcohol having a viscosity of 2920 cp. The inherent viscosity of the polymer is 0.435. The nitrogen content is 0.59 ~'o.
Example 7: 1.3 g (8.5 mmol) of 2-isocyanatoethyl rnethacrylate are added to 200 ml of the polymer solution of Example 6 and the pH maintained at 10 with 2N sodium hydroxide solution. After 15 minutes at room temperature the solution is neutralised with 2N hydro-chloric acid and ultrafiltered analogously to Example 6. Concentration yields a 27.1 %
polymer solution of the 4-(2-methacryloylethyl-ureido)butyraldehydo-1,3-acetal of poly-vinyl alcohol having a viscosity of 2320 cp. The inherent viscosity of the polymer is 0.390. The nitrogen content is 1.9 %.
Example 8: 0.7 % Darocure 1173 (based on the content of polymer) is added to the 30.8 %
polymer solution according to Example 4 having a viscosity of approximately 3600 cp.
The solution is introduced into a transparent contact lens mould of polypropylenevand the mould is closed. The solution is irradiated for 6 seconds from a distance of 18 cm using a 200 watt OrielTM LTV lamp. The mould is opened and the finished contact lens can be removed. The contact lens is transparent and has a water content of 61 %. The modulus is 0.9 mPa, the flexural elongation 50 %. The contact lens is autoclaved for 40 minutes at 121°C. No changes in shape can be detected in a contact lens treated in that manner.
Examyle 9: 0.0268 g of Darocure 1173 (0.7 % based on the polymer content) and 0.922 g of methyl methacrylate are added to 10.00 g of a 27.1 % polymer solution according to Example 7. After the addition of 2.3 g of methanol a clear solution is obtained. That solution is irradiated for a period of 14 seconds analogously to Example 8, using a 200 watt OrieITM lamp. A transparent contact lens having a water content of 70.4% is obtained.
Example 10: 1.04 g of acrylamide and 0.03 g of Darocure 1173 are added to 12.82 g of a 24.16 % solution of the prepolymer of Example 4. The clear solution is then irradiated for 14 seconds analogously to Example 8, using a 200 watt Oriel T"" lamp. A
contact lens having a water content of 64.4 % is obtained.
Example 11: 220 g (5.5 mol) of sodium hydroxide are dissolved in 300 g of water and 700 g of ice in a 3-litre reactor having a stirrer and a cooling system. The sodium hydroxide solution is cooled to 10°C and 526 g (5.0 mol) of aminoacetaldehyde dimethyl-acetal and 50 mg of 4-hydroxy-2,2,6,6-tetramethylpiperidin-1-oxide (radical inhibitor) are added. 548.6 g (5.5 mol) of methacrylic acid chloride are slowly added at 10°C to the solution over a period of 3.5 hours. When the addition is complete, the pH
value drops slowly to 7.2 and amine can no longer be detected by GC. The reaction mixture is extracted with 500 ml of petroleum ether, and in order to remove impurities, the aqueous phase is saturated with sodium chloride and extracted three times with 500 ml of tent-butyl methyl ether. The organic phase is dried with magnesium sulfate, filtered and concentrated using a rotary evaporator. The resulting 882.2 g of yellowish oil are slowly stirred into 2000 ml of petroleum ether at -10°C by means of an Ultraturax. The product crystallises, and is isolated by filtration and dried. 713.8 g of methacrylamidoacetaldehyde dimethyl-acetal (86 % of theory), melting point 30-32°C, are obtained; the product is 99.7 %
according to GC.
Example 12: 40 g (1.0 mol) of sodium hydroxide are dissolved in 100 g of water and 200 g of ice in a 1-litre reactor having a stirrer and a cooling system. The sodium hydroxide solution is cooled to 10°C, and 105.1 g (1.0 mol) of aminoacetaldehyde dimethylacetal and 10 mg of the inhibitor 4-hydroxy-2,2,6,6-tetramethylpiperidin-1-oxide ane added.
99.5 g (1.1 mol) of acrylic acid chloride are slowly added to that solution at 10°C over a period of 2 hours. The pH value drops slowly and ultimately is adjusted to 7.
According to GC, amine is no longer present. The reaction mixture is saturated with sodium chloride and extracted three times with 200 ml of ten-butyl methyl ether. The organic phase is dried, filtered and concentrated using a rotary evaporator. The resulting oil is extracted three times with petroleum ether and then dried again using a rotary evaporator. 130~g of acrylamidoacetaldehyde dimethylacetal (81 % of theory) are obtained in the form of an oil; the product is 99 % according to GC.
Example 13: General preparative method for the reaction of PVA with acetals or aldehydes for the preparation of reaction products having a high acetate content 300 g of PVA (for example Moviol Hoechst 4-88) are placed in a 2-litre double jacket reactor having a stirrer and thermometer, 800 g of deionised water are added, and the mixture is heated to 95°C with stirring. After one hour, everything has dissolved to produce a clear solution which is cooled to 20°C. 27 g (0.155 mol) of methacrylamido-acetaldehyde dimethyl acetal (from Example 11), 440 g of acetic acid, 100 g of concen-trated hydrochloric acid (37 %) and sufficient deionised water (in this specific case: 333 g) are added to produce a total of 2000 g of reaction solution. The mixture is stirred for 20 hours at 20°C. The change in the acetate content can be ascertained by titration of the acetic acid.
Isolation can be carried out by means of ultrafiltration: the reaction mixture is cooled to 15°C and adjusted to pH 3.6 with aqueous NaOH (5 %). The polymer solution is filtered by way of a 0.45 ltm filter and purified by means of ultrafiltration. The ultrafiltration is carried out using a 1-KD-Omega membrane produced by Filtron. Ultrafiltration is carried out to a residual sodium chloride content of 0.004 %. Before the purification is complete, the solution is adjusted to pH 7 with O.1N sodium hydroxide solution.
Concentration yields 1995 g of a 14.54 % polymer solution (92 % of theory); N-content (Kjendahl deter-mination) = 0.683 %, acetate content (ascertained by hydrolysis) = 2.34 meq/g, inherent viscosity: 0.310, double bonds: 0.5 meq/g (ascertained by microhydrogenation), free hydroxy groups (ascertained by reacetylation): 15.3 meq/g, GPC analysis (in water):
Mw=19 101, Mn=7 522, Mw/Mn=2.54.
The isolation can also be carried out by means of precipitation: the reaction mixture is adjusted to pH 3.6 with triethylamine and precipitated in acetone in a ratio of 1:10. The precipitate is separated off, dispersed twice with ethanol and once with acetone, and dried.
The product so obtained has the same properties as the product obtained by ultrafiltration.
Example 14: General preparative method for the reaction of PVA with acetals or aldehydes for the preparation of reaction products having a low acetate content.
300 g of PVA (for example Moviol Hoechst 4-88) are placed in a 2-litre double jacket reactor having a stirrer and thermometer, 800 g of deionised water are added and the mixture is heated to 95°C with stirring. After one hour, everything has dissolved to produce a clear solution which is cooled to 20°C. 27 g (0.155 mol) of methacrylamido-acetaldehyde dimethyl acetal (from Example 11), 200 g of concentrated hydrochloric acid (37 %) and sufficient deionised water (in this specific case: 673 g) are added to produce a total of 2000 g of reaction solution. The mixture is stirred at 20°C.
After 20 hours, a sample of the reaction solution is titrated with sodium hydroxide and the degree of hydrolysis of the PVA is ascertained: HCl = 1.034 meq/g, acetic acid = 0.265 meq/g corresponding to 3.5 mol % residual acetate. The reaction mixture is stirred for a further 2 hours at 25°C and titrated again. HCl = 1.034 meq/g, acetic acid =
0.277 meq/g, corres-ponding to 2.93 mol % residual acetate.
The isolation can be carried out by means of ultrafiltration: the reaction mixture is cooled to 15°C and adjusted to pH 7 with aqueous NaOH (5 %). The polymer solution is filtered by way of a 0.45 ~m filter and purified by means of ultrafiltration. The ultrafiltration is carried out using a 1-KD-Omega membrane produced by Filtron. Ultrafiltration is carried out to a residual sodium chloride content of 0.002 %. 1800 g of a 14.02 %
polymer solution (86 % of theory) are obtained; N-content (Kjendahl determination) =
0.741 %, acetate content (after titration) = 0.605 meq/g corresponding to 2.91 mol %, inherent viscosity: 0.327, double bonds: 0.61 meq/g (ascertained by microhydrogenation), free hydroxy groups (ascertained by reacetylation): 18.13 meq/g, GPC analysis (in water):
Mw = 22 007, Mn = 9 743, Mw/Mn = 2.26.
The isolation can also be carried out by means of precipitation: the reaction mixture is adjusted to pH 3.6 with triethylamine and precipitated in acetone in a ratio of 1:10. The precipitate is separated off, dispersed twice with ethanol and once with acetone, and dried.
The product so obtained is comparable with that obtained by ultrafiltration.
Example 15: Manufacture of contact lenses 0.3 % (based on polymer content) of the photoinitiator Irgacure 2959 is added to a 30 %
solution of the polymers listed below. The solutions are irradiated for 6 seconds in a trans-parent contact lens mould of polypropylene using a 200 W OrieIT"' UV lamp (150 mW/cm2).
The lenses are removed from the mould. They are transparent and have the properries listed below.
Examples 15a) to 15j): reaction products of PVA (4-88) Moviol Hoechst, 12 mol %
residual acetate, Mw = 19 115, Mn = 7887, Mw/Mn = 2.43, inherent viscosity =
0.35$, in accordance with the preparative method of Example 13 or 14, isolation by ultrafiltration:
15 a): 30 g of acetal from Example 11, preparative method according to Example 13, acetic acid addition: 700 g, inherent viscosity: 0.278, prepolymer data (sol): N content: 1.34 %, acetal content: 0.96 meq/g, acetate content: 19 mol %, Mw: 17 412, Mn: 6273, Mw/Mn: 2.77, solids content: 30 % in the sol state results in 38.4 % in the gel state.
15 b): 24 g of acetal from Example 11, preparative method according to Example 13, acetic acid addition: 300 g, inherent viscosity: 0.329, prepolymer data (sol): N content: 0.64 %, aceta.l content: 0.45 meq/g, acetate content: 9 mol %, solids content: 30 % in the sol state results in 29.5 % in the gel state.
15 c): 24 g of acetal from Example 11, preparative method according to Example 13, acetic acid addition: 700 g, inherent viscosity: 0.331, prepolymer data (sol): N content: 0.58 %, acetal content: 0.42 meq/g, acetate content: 17.5 mol %, Mw: 18 861, Mn: 8051, Mw/Mn: 2.34, solids content: 30 % in the sol state results in 27.6 % in the gel state.
15 d): 30 g of acetal from Example 11, preparative method according to Example 13, acetic acid addition: 500 g, inherent viscosity: 0.327, prepolymer data (sol): N content: 0.753 %, acetal content: 0.54 meq/g, acetate content: 12.5 mol %, Mw: 19 463, Mn: 8064, Mw/Mn: 2.41, solids content: 30 % in the sol state results in 30.0 % in the gel state.
15 e): 56 g of acetal from Example 1 l, preparative method according to Example 13, acetic acid addition: 1000 g, prepolymer data (sol): N content: 1.208 %, acetal content: 0.86 meq/g, acetate content: 26 mol %, solids content: 30 % in the sol state results in 36.7 % in the gel state.
15 f): 24 g of acetal from Example 11, preparative method according to Example 14, no acetic acid addition, inherent viscosity: 0.321, prepolymer data (sol): N content: 0.659 %, acetal content: 0.46 meq/g, acetate content: 5.9 mol %, Mw: 27 121, Mn: 6490, Mw/Mn: 4.18, solids content: 30 % in the sol state results in 30.0 % in the gel state.
15 g): 48 g of acetal from Example 11, preparative method according to Example 14, no acetic acid addition, prepolymer data (sol): N content: 1.23 %, acetal content: 0.88 meq/g, acetate content: 6.6 mol %, Mw: 18 833, Mn: 7047, Mw/Mn: 2.66, solids content: 30 % in the sol state results in 36.7 % in the gel state.
15 h): 27 g of acetal from Example 11, preparative method according to Example 14, no acetic acid addition, inherent viscosity: 0.31, prepolymer data (sol): N content: 0.638 %, acetal content: 0.53 meq/g, acetate content: 2.9 mol %, Mw: 19 101, Mn: 7522, Mw/Mn: 2.54, solids content: 30 % in the sol state results in 30.0 % in the gel state.
15 i): 31 g of acetal from Example 12, preparative method according to Example 14, no acetic acid addition, prepolymer data (sol): N content: 1.41 %, acetal content: 1.00 meq/g, acetate content: 6.2 mol %, solids content: 30 % in the sol state results in 37.0 % in the gel state.
15 j): 23 g of acetal from Example 12, preparative method according to Example 14, no acetic acid addition, inherent viscosity: 0.352, prepolymer data (sol): N content: 0.62 %, acetal content: 0.44 meq/g, acetate content: 5.8 mol %.
Examples 15 k) to 151): Reaction products of PVA (8-88) Moviol Hoechst, 12 mol %
residual acetate, Mw = 49 000, Mn = 19 600, Mw/Mn = 2.5, inherent viscosity =
0.546, according to the preparative method of Example 13, isolation by ultraflltration:
15 k): 53 g of acetal from Example 11, acetic acid addition: 400 g, prepolymer data (sol): N content: 1.31 %, acetal content: 0.94 meq/g, acetate content: 8.9 mol %, 15 1): 30 g of acetal from Example 11, acetic acid addition: 490 g, inherent viscosity:
0.495, prepolymer data (sol): N content: 0.747 %, acetal content: 0.54 meq/g, acetate content: 13.6 mol %, Mw: 44 334, Mn: 17 293, Mw/Mn: 2.56, solids content: 30 %~in the sol state results in 30.5 % in the gel state.
Claims (18)
1. ~A prepolymer, that is a polyvinyl alcohol having a molecular weight of at least 2000 that, based on the number of hydroxy groups of the polyvinyl alcohol, comprises from 0.5 to 80% of units of formula III
wherein R is alkylene having up to 8 carbon atoms, R1 is hydrogen or alkyl having up to 7 carbon atoms, p is zero or one, q is zero or one, R3 is an olefinically unsaturated copolymerisable radical having from 2 to 8 carbon atoms, and R4 and R5 are each independently alkylene having from 2 to 8 carbon atoms, arylene having from 6 to 12 carbon atoms, a saturated divalent cycloaliphatic group having from 6 to 10 carbon atoms, arylenealkylene or alkylenearylene having from 7 to 14 carbon atoms or arylenealkylenearylene having from 13 to 16 carbon atoms.
wherein R is alkylene having up to 8 carbon atoms, R1 is hydrogen or alkyl having up to 7 carbon atoms, p is zero or one, q is zero or one, R3 is an olefinically unsaturated copolymerisable radical having from 2 to 8 carbon atoms, and R4 and R5 are each independently alkylene having from 2 to 8 carbon atoms, arylene having from 6 to 12 carbon atoms, a saturated divalent cycloaliphatic group having from 6 to 10 carbon atoms, arylenealkylene or alkylenearylene having from 7 to 14 carbon atoms or arylenealkylenearylene having from 13 to 16 carbon atoms.
2. ~The prepolymer according to claim 1, wherein R is alkylene having up to 6 carbon atoms, p is zero, and R3 is alkenyl having from 2 to 8 carbon atoms.
3. ~The prepolymer according to claim 2, wherein R3 is alkenyl having from 2 to 4 carbon atoms.
4. ~The prepolymer according to claim 1, wherein R is alkylene having up to 6 carbon atoms, p is one, q is zero, R5 is alkylene having from 2 to 6 carbon atoms, and R3 is alkenyl having from 2 to 8 carbon atoms.
5. ~A prepolymer, that is a polyvinyl alcohol having a molecular weight of at least 2000 that, based on the number of hydroxy groups of the polyvinyl alcohol, comprises from 0.5 to 80% of units of formula III
wherein R is alkylene having up to 6 carbon atoms, R1 is hydrogen or alkyl having up to 7 carbon atoms, p is one, q is one, R4 is alkylene having from 2 to 6 carbon atoms, phenylene, unsubstituted or substituted by alkyl having up to 7 carbon atoms, cyclohexylene or cyclohexylene-C1-C7-alkylene, unsubstituted or substituted by alkyl having up to 7 carbon atoms, phenylene-C1-C7-alkylene, C1-C7-alkylene-phenylene or phenylene-C1-C7-alkylene-phenylene, R5 is alkylene having from 2 to 6 carbon atoms, and R3 is alkenyl having from 2 to 8 carbon atoms.
wherein R is alkylene having up to 6 carbon atoms, R1 is hydrogen or alkyl having up to 7 carbon atoms, p is one, q is one, R4 is alkylene having from 2 to 6 carbon atoms, phenylene, unsubstituted or substituted by alkyl having up to 7 carbon atoms, cyclohexylene or cyclohexylene-C1-C7-alkylene, unsubstituted or substituted by alkyl having up to 7 carbon atoms, phenylene-C1-C7-alkylene, C1-C7-alkylene-phenylene or phenylene-C1-C7-alkylene-phenylene, R5 is alkylene having from 2 to 6 carbon atoms, and R3 is alkenyl having from 2 to 8 carbon atoms.
6. The prepolymer according to claim 1, which is a polyvinyl alcohol having a molecular weight of at least 2000 that, based on the number of hydroxy groups of the polyvinyl alcohol, comprises from 1 to 15% of units of formula III.
7. A polymer, obtained by photocrosslinking a prepolymer according to any one of claims 1 to 6 in the absence or presence of an additional vinylic comonomer.
8. The polymer according to claim 7, wherein the prepolymer is previously converted into a pure form by a single or by repeated ultrafiltration.
9. The polymer according to claim 7, obtained by photocrosslinking the prepolymer according to any one of claims 1 to 6 in the absence of an additional vinylic comonomer.
10. The polymer according to claim 7, obtained by photocrosslinking the prepolymer according to any one of claims 1 to 6 in the presence of from 0.5 to 80 units of an additional vinylic comonomer per unit of formula III.
11. The polymer according to claim 10, obtained by photocrosslinking the prepolymer according to any one of claims 1 to 6 in the presence of from 1 to 30 units of the additional vinylic comonomer per unit of formula III.
12. The polymer according to claim 11, obtained by photocrosslinking the prepolymer according to any one of claims 1 to 6 in the presence of from 5 to 20 units of the additional vinylic comonomer per unit of formula III.
13. A process for the preparation of a polymer, which comprises photocrosslinking a prepolymer according to any one of claims 1 to 6 in the absence or presence of an additional vinylic comonomer.
14. The process according to claim 13, wherein the prepolymer is previously converted into a pure form by a single or by repeated ultrafiltration.
15. The process according to claim 13, which is carried out in solution.
16. The process according to claim 15, wherein the solution is an aqueous solution.
17. A moulding consisting substantially of a polymer according to claim 7.
18. The moulding according to claim 17, which is a contact lens.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH235093 | 1993-08-06 | ||
CH2350/93-0 | 1993-08-06 | ||
CA002129461A CA2129461C (en) | 1993-08-06 | 1994-08-04 | Photocrosslinked polymers |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002129461A Division CA2129461C (en) | 1993-08-06 | 1994-08-04 | Photocrosslinked polymers |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2221162A1 CA2221162A1 (en) | 1995-02-07 |
CA2221162C true CA2221162C (en) | 2003-10-07 |
Family
ID=4231738
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002129461A Expired - Lifetime CA2129461C (en) | 1993-08-06 | 1994-08-04 | Photocrosslinked polymers |
CA002221162A Expired - Lifetime CA2221162C (en) | 1993-08-06 | 1994-08-04 | Photocrosslinked polymers and prepolymers thereof |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002129461A Expired - Lifetime CA2129461C (en) | 1993-08-06 | 1994-08-04 | Photocrosslinked polymers |
Country Status (26)
Country | Link |
---|---|
US (4) | US5508317A (en) |
EP (2) | EP0641806B1 (en) |
JP (1) | JP2914872B2 (en) |
KR (1) | KR100336138B1 (en) |
CN (1) | CN1062513C (en) |
AT (2) | ATE251183T1 (en) |
AU (2) | AU680507B2 (en) |
BR (1) | BR9403174A (en) |
CA (2) | CA2129461C (en) |
CZ (2) | CZ289627B6 (en) |
DE (2) | DE59405162D1 (en) |
DK (2) | DK0641806T3 (en) |
ES (2) | ES2208779T3 (en) |
FI (2) | FI114714B (en) |
GR (1) | GR3026098T3 (en) |
HK (1) | HK1005338A1 (en) |
HU (2) | HU228123B1 (en) |
IL (3) | IL110487A (en) |
NO (3) | NO942908D0 (en) |
NZ (2) | NZ286397A (en) |
PL (1) | PL178192B1 (en) |
PT (1) | PT790258E (en) |
RU (1) | RU2141896C1 (en) |
SG (1) | SG49623A1 (en) |
TW (1) | TW272976B (en) |
ZA (1) | ZA945872B (en) |
Families Citing this family (281)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5800373A (en) * | 1995-03-23 | 1998-09-01 | Focal, Inc. | Initiator priming for improved adherence of gels to substrates |
US6800225B1 (en) | 1994-07-14 | 2004-10-05 | Novartis Ag | Process and device for the manufacture of mouldings and mouldings manufactured in accordance with that process |
US6407145B1 (en) * | 1994-08-04 | 2002-06-18 | Novartis Ag | Photocrosslinkable materials and applications |
EP0807017B1 (en) * | 1995-02-02 | 1999-10-20 | Novartis AG | Process for the manufacture of moulded articles that are partly coloured or have regions of different colours |
TW360671B (en) * | 1995-02-03 | 1999-06-11 | Novartis Ag | Process for producing mold body and the cross-linkable polymer used therein |
AU4620596A (en) * | 1995-02-03 | 1996-08-21 | Novartis Ag | Crosslinked polymers containing ester or amide groups |
TW349967B (en) | 1995-02-03 | 1999-01-11 | Novartis Ag | Process for producing contact lenses and a cross-linkable polyvinylalcohol used therefor |
CN1173228A (en) * | 1995-02-03 | 1998-02-11 | 诺瓦提斯公司 | Crosslinked polymers containing photoinitiators |
AU4438696A (en) * | 1995-02-03 | 1996-08-21 | Novartis Ag | Crosslinked polymers |
TW425410B (en) * | 1995-02-03 | 2001-03-11 | Novartis Ag | Preparation of the crosslinked tinted polymers and their moldings |
JP4209941B2 (en) | 1995-03-23 | 2009-01-14 | ジェンザイム・コーポレーション | Undercoat redox and photoinitiator systems for improved adhesion of gels to substrates |
US5900245A (en) * | 1996-03-22 | 1999-05-04 | Focal, Inc. | Compliant tissue sealants |
WO1997005185A2 (en) | 1995-07-28 | 1997-02-13 | Focal, Inc. | Multiblock biodegradable hydrogels for use as controlled release agents for drugs delivery and tissue treatment agents |
TW448205B (en) * | 1996-05-23 | 2001-08-01 | Novartis Ag | Process for the manufacture of storage-stable hydrogel-moldings |
ID17663A (en) * | 1996-07-26 | 1998-01-15 | Novartis Ag | MOLD MAKING-MOLD |
AR008108A1 (en) * | 1996-08-01 | 1999-12-09 | Novartis Ag | A METHOD FOR FORMING A RADIATION ABSORBENT POLYMERIC ARTICLE, A POLYMERIC ARTICLE SO FORMED, AND A METHOD FOR FORMING A POLYMERIC DYE |
ZA978537B (en) | 1996-09-23 | 1998-05-12 | Focal Inc | Polymerizable biodegradable polymers including carbonate or dioxanone linkages. |
US6113817A (en) * | 1997-03-25 | 2000-09-05 | Novartis Ag | Molding processes |
NZ337346A (en) * | 1997-03-25 | 2001-06-29 | Novartis Ag | Two-part mold comprising a crosslinked polymer formed by exposure to UV light |
JP2002501626A (en) * | 1997-05-27 | 2002-01-15 | ノバルティス アクチエンゲゼルシャフト | Compound eye lens |
US6265509B1 (en) * | 1997-07-30 | 2001-07-24 | Novartis Ag | Crosslinked polymers |
US6402995B1 (en) * | 1997-07-31 | 2002-06-11 | Seed Co., Ltd. | Process for preparing polyvinyl alcohol contact lenses |
ATE224549T1 (en) * | 1997-08-28 | 2002-10-15 | Novartis Erfind Verwalt Gmbh | METHOD AND COMPOSITION FOR MIXING RADIATION ABSORBING MATERIAL WITH POLYMERS |
ES2195435T3 (en) * | 1997-11-14 | 2003-12-01 | Novartis Ag | PROCEDURES AND COMPOSITIONS FOR THE PRODUCTION OF Tinted Ophthalmic Lenses. |
US5997140A (en) * | 1997-12-29 | 1999-12-07 | Novartis Ag | Actively controllable multifocal lens |
US6139147A (en) * | 1998-11-20 | 2000-10-31 | Novartis Ag | Actively controllable multifocal lens |
US6139146A (en) * | 1997-12-29 | 2000-10-31 | Novartis Ag | Programmable corrective lenses |
US5981617A (en) * | 1998-01-20 | 1999-11-09 | Kim; Hee Jung | Irradiation of gas permeable contact lenses by far infrared light |
US6217171B1 (en) | 1998-05-26 | 2001-04-17 | Novartis Ag | Composite ophthamic lens |
US6149692A (en) * | 1998-08-27 | 2000-11-21 | Novartis Ag | Method and composition for incorporating radiation-absorbing agents into polymers |
EP1050470A1 (en) | 1999-05-04 | 2000-11-08 | Novartis AG | Detection of ophthalmic mouldings in a package |
EP1057730A1 (en) | 1999-05-04 | 2000-12-06 | Novartis AG | Method and apparatus for determining ophtalmic moulded bodies in a package |
JP4717304B2 (en) * | 1999-06-25 | 2011-07-06 | ノバルティス アーゲー | UV illumination device |
US6638451B1 (en) * | 1999-08-31 | 2003-10-28 | Novartis Ag | Plastic casting molds |
US7279176B1 (en) | 1999-09-02 | 2007-10-09 | Rice University | Nitric oxide-producing hydrogel materials |
US7052711B2 (en) * | 1999-09-02 | 2006-05-30 | Rice University | Nitric oxide-producing hydrogel materials |
EP1229956B1 (en) * | 1999-09-15 | 2007-01-10 | Resmed Ltd. | Patient-ventilator synchronization using dual phase sensors |
US6710126B1 (en) | 1999-11-15 | 2004-03-23 | Bio Cure, Inc. | Degradable poly(vinyl alcohol) hydrogels |
EP1109011B1 (en) | 1999-12-03 | 2009-09-02 | Novartis AG | Method for detecting the presence of mouldings in a package |
WO2001049824A2 (en) * | 2000-01-05 | 2001-07-12 | Novartis Ag | Cell growth substrate hydrogels |
US7998412B2 (en) | 2000-01-07 | 2011-08-16 | Smart Holograms Limited | Ophthalmic device comprising a holographic sensor |
JP4871476B2 (en) | 2000-03-13 | 2012-02-08 | バイオコンパティブルズ ユーケー リミテッド | Embolization composition |
US6652883B2 (en) * | 2000-03-13 | 2003-11-25 | Biocure, Inc. | Tissue bulking and coating compositions |
WO2001068722A1 (en) * | 2000-03-13 | 2001-09-20 | Biocure, Inc. | Hydrogel biomedical articles |
EP1266246B1 (en) * | 2000-03-24 | 2004-06-02 | Novartis AG | Crosslinkable or polymerizable prepolymers |
DE60110422T2 (en) | 2000-06-26 | 2006-02-16 | Novartis Ag | POLYURETHANE hydrogel |
US6364934B1 (en) | 2000-07-31 | 2002-04-02 | Bausch & Lomb Incorporated | Method of making ocular devices |
US6737661B2 (en) * | 2000-08-17 | 2004-05-18 | Novartis Ag | Pre-treatment of molds |
US20020093701A1 (en) * | 2000-12-29 | 2002-07-18 | Xiaoxiao Zhang | Holographic multifocal lens |
US6774178B2 (en) | 2001-01-05 | 2004-08-10 | Novartis Ag | Tinted, high Dk ophthalmic molding and a method for making same |
ATE317758T1 (en) * | 2001-01-24 | 2006-03-15 | Novartis Pharma Gmbh | METHOD FOR PRODUCING LENSES |
TWI261057B (en) * | 2001-03-07 | 2006-09-01 | Novartis Ag | Process for the manufacture of moldings |
WO2002072166A1 (en) * | 2001-03-13 | 2002-09-19 | Biocure, Inc. | Compositions for drug delivery |
JP2002355830A (en) * | 2001-03-26 | 2002-12-10 | Novartis Ag | Mold and method for producing ophthalmic lens |
DE20107040U1 (en) * | 2001-04-24 | 2002-10-02 | Novartis Ag | metering lance |
US6997693B2 (en) * | 2001-10-19 | 2006-02-14 | Novartis Ag | Casting mold half and casting mold for producing contact lenses |
US7411008B2 (en) * | 2001-11-07 | 2008-08-12 | Novartis Ag | Ink formulations and uses thereof |
EP1460982A4 (en) * | 2001-11-16 | 2010-04-14 | Biocure Inc | Methods for initiating in situ formation of hydrogels |
US20060100408A1 (en) * | 2002-03-11 | 2006-05-11 | Powell P M | Method for forming contact lenses comprising therapeutic agents |
US6846892B2 (en) * | 2002-03-11 | 2005-01-25 | Johnson & Johnson Vision Care, Inc. | Low polydispersity poly-HEMA compositions |
US20030209818A1 (en) * | 2002-05-13 | 2003-11-13 | Harald Bothe | Pretreatment of contact lens moulds |
US6936641B2 (en) | 2002-06-25 | 2005-08-30 | Johnson & Johnson Vision Care, Inc. | Macromer forming catalysts |
DE60317797T2 (en) * | 2002-08-14 | 2008-10-30 | Novartis Ag | RADIATION-HARDENABLE PREPOLYMERS |
EP1543082B1 (en) * | 2002-09-03 | 2010-11-24 | Novartis AG | Ink formulation and uses thereof |
US7235195B2 (en) * | 2002-09-06 | 2007-06-26 | Novartis Ag | Method for making opthalmic devices |
US20080299179A1 (en) * | 2002-09-06 | 2008-12-04 | Osman Rathore | Solutions for ophthalmic lenses containing at least one silicone containing component |
US7429465B2 (en) | 2002-09-13 | 2008-09-30 | Novartis Ag | Process for analyzing tear fluid |
JP2004151691A (en) * | 2002-09-30 | 2004-05-27 | Rohm & Haas Electronic Materials Llc | Improved photoresist |
US7148265B2 (en) * | 2002-09-30 | 2006-12-12 | Rohm And Haas Electronic Materials Llc | Functional polymer |
JP2004163904A (en) * | 2002-09-30 | 2004-06-10 | Rohm & Haas Electronic Materials Llc | Improved photoinitiator |
US20050085585A1 (en) * | 2002-10-23 | 2005-04-21 | Quinn Michael H. | Polymerizable materials |
US7049351B2 (en) * | 2002-11-01 | 2006-05-23 | Novartis Ag | Moldings and preparation and uses thereof |
US20050038329A1 (en) * | 2002-11-20 | 2005-02-17 | Morris Carol Ann | Methods and kits for assays of rapid screening of diabetes |
US20040224259A1 (en) * | 2002-12-12 | 2004-11-11 | Shipley Company, L.L.C. | Functionalized polymer |
US20040161466A1 (en) | 2003-02-14 | 2004-08-19 | Biocompatibles Uk Limited | Chemoembolisation |
WO2004076500A1 (en) * | 2003-02-28 | 2004-09-10 | Novartis Ag | Copolymers comprising biomolecules |
JP2006521180A (en) * | 2003-03-25 | 2006-09-21 | バイオキュア・インコーポレーテッド | Medical device with hydrogel yarn |
WO2005000109A2 (en) * | 2003-06-27 | 2005-01-06 | University Of Maryland Biotechnology Institute | Quaternary nitrogen heterocyclic compounds for detecting aqueous monosaccharides in physiological fluids |
EP1651946A1 (en) * | 2003-07-30 | 2006-05-03 | Novartis AG | Reflection hologram sensor in contact lens |
WO2005015237A1 (en) * | 2003-08-07 | 2005-02-17 | Novartis Ag | Ophthalmic sensor |
US20050056954A1 (en) * | 2003-09-12 | 2005-03-17 | Devlin Brian Gerrard | Method for making contact lenses |
WO2005077013A2 (en) | 2004-02-06 | 2005-08-25 | Georgia Tech Research Corporation | Surface directed cellular attachment |
WO2005077304A1 (en) | 2004-02-06 | 2005-08-25 | Georgia Tech Research Corporation | Load bearing biocompatible device |
US20050271727A1 (en) * | 2004-06-07 | 2005-12-08 | Callisyn Pharmaceuticals, Inc. | Biodegradable and biocompatible crosslinked polymer hydrogel prepared from PVA and/or PEG macromer mixtures |
US7666225B2 (en) * | 2004-06-29 | 2010-02-23 | Hassan Chaouk | Spinal disc nucleus pulposus implant |
WO2006027567A2 (en) | 2004-09-07 | 2006-03-16 | Biocompatibles Uk Limited | Drug delivery from embolic agents |
US8030369B2 (en) * | 2004-10-13 | 2011-10-04 | Novartis Ag | Contact lenses with improved wearing comfort |
WO2006085351A1 (en) † | 2005-02-09 | 2006-08-17 | Safilens S.R.L. | Contact lens, method for producing same, and pack for storage and maintenance of a contact lens |
US20060192310A1 (en) * | 2005-02-23 | 2006-08-31 | Lindacher Joseph M | Method of manufacturing ophthalmic lenses using modulated energy |
US7795359B2 (en) | 2005-03-04 | 2010-09-14 | Novartis Ag | Continuous process for production of polymeric materials |
WO2006097306A2 (en) * | 2005-03-18 | 2006-09-21 | Novartis Ag | Pad printing apparatus for making colored contact lenses |
DE602006007124D1 (en) * | 2005-04-29 | 2009-07-16 | Novartis Ag | COATED LENS FORMS AND METHOD FOR PRODUCING A CONTACT LENS |
US9804295B2 (en) | 2005-05-05 | 2017-10-31 | Novartis Ag | Ophthalmic devices for sustained delivery of active compounds |
US20070037897A1 (en) | 2005-08-12 | 2007-02-15 | Guigui Wang | Method for making contact lenses |
US20070149641A1 (en) * | 2005-12-28 | 2007-06-28 | Goupil Dennis W | Injectable bone cement |
EP2520287A1 (en) | 2006-02-10 | 2012-11-07 | Biocompatibles UK Limited | Loading of hydrophobic drugs into hydrophilic polymer delivery systems |
EP1998907B1 (en) | 2006-02-28 | 2011-02-16 | Cellular Bioengineering, Inc. | Polymer composition and method for removing contaminates from a substrate |
US7858000B2 (en) * | 2006-06-08 | 2010-12-28 | Novartis Ag | Method of making silicone hydrogel contact lenses |
DK2038310T3 (en) | 2006-07-12 | 2010-09-27 | Novartis Ag | Actinically crosslinkable copolymers for making contact lenses |
US20080081851A1 (en) * | 2006-09-01 | 2008-04-03 | Benz Patrick H | Optical polymers with higher refractive index |
US20080124376A1 (en) * | 2006-11-06 | 2008-05-29 | Novartis Ag | Ocular devices and methods of making and using thereof |
AR064286A1 (en) * | 2006-12-13 | 2009-03-25 | Quiceno Gomez Alexandra Lorena | PRODUCTION OF OPHTHALMIC DEVICES BASED ON POLYMERIZATION BY PHOTOINDUCIDED SCALE GROWTH |
US8394483B2 (en) | 2007-01-24 | 2013-03-12 | Micron Technology, Inc. | Two-dimensional arrays of holes with sub-lithographic diameters formed by block copolymer self-assembly |
US8083953B2 (en) | 2007-03-06 | 2011-12-27 | Micron Technology, Inc. | Registered structure formation via the application of directed thermal energy to diblock copolymer films |
US8557128B2 (en) * | 2007-03-22 | 2013-10-15 | Micron Technology, Inc. | Sub-10 nm line features via rapid graphoepitaxial self-assembly of amphiphilic monolayers |
EP2126614B1 (en) | 2007-03-22 | 2019-04-24 | Novartis AG | Silicone-containing prepolymers with hydrophilic polymeric chains |
JP5484916B2 (en) | 2007-03-22 | 2014-05-07 | ノバルティス アーゲー | Prepolymer having dangling polysiloxane-containing polymer chain |
US7959975B2 (en) * | 2007-04-18 | 2011-06-14 | Micron Technology, Inc. | Methods of patterning a substrate |
US8097175B2 (en) | 2008-10-28 | 2012-01-17 | Micron Technology, Inc. | Method for selectively permeating a self-assembled block copolymer, method for forming metal oxide structures, method for forming a metal oxide pattern, and method for patterning a semiconductor structure |
US8294139B2 (en) | 2007-06-21 | 2012-10-23 | Micron Technology, Inc. | Multilayer antireflection coatings, structures and devices including the same and methods of making the same |
US8372295B2 (en) | 2007-04-20 | 2013-02-12 | Micron Technology, Inc. | Extensions of self-assembled structures to increased dimensions via a “bootstrap” self-templating method |
EP2152779B1 (en) | 2007-05-11 | 2018-10-24 | Aeris Therapeutics, LLC | Lung volume reduction therapy using crosslinked non-natural polymers |
DE102007024642A1 (en) | 2007-05-24 | 2008-11-27 | Eyesense Ag | Hydrogel implant for sensor of metabolites on the eye |
US8404124B2 (en) * | 2007-06-12 | 2013-03-26 | Micron Technology, Inc. | Alternating self-assembling morphologies of diblock copolymers controlled by variations in surfaces |
US8080615B2 (en) | 2007-06-19 | 2011-12-20 | Micron Technology, Inc. | Crosslinkable graft polymer non-preferentially wetted by polystyrene and polyethylene oxide |
CA2690843A1 (en) * | 2007-06-19 | 2008-12-24 | Garry Edgington | Method for treating microorganisms and/or infectious agents |
JP5313242B2 (en) * | 2007-06-19 | 2013-10-09 | セルラー・バイオエンジニアリング・インコーポレイテッド | Method for protecting a substrate and removing contaminants from the substrate |
TWI551305B (en) | 2007-08-31 | 2016-10-01 | 諾華公司 | Use of a relatively-viscous packaging solution |
US8044111B2 (en) | 2007-11-30 | 2011-10-25 | Novartis Ag | Actinically-crosslinkable silicone-containing block copolymers |
WO2009073205A1 (en) * | 2007-12-07 | 2009-06-11 | Biocure, Inc. | Bone substitute |
MY154718A (en) | 2007-12-10 | 2015-07-15 | Novartis Ag | Method for making silicone hydrogel contact lenses |
WO2009085902A1 (en) | 2007-12-20 | 2009-07-09 | Novartis Ag | Method for making contact lenses |
US8999492B2 (en) | 2008-02-05 | 2015-04-07 | Micron Technology, Inc. | Method to produce nanometer-sized features with directed assembly of block copolymers |
US8101261B2 (en) | 2008-02-13 | 2012-01-24 | Micron Technology, Inc. | One-dimensional arrays of block copolymer cylinders and applications thereof |
US8426313B2 (en) | 2008-03-21 | 2013-04-23 | Micron Technology, Inc. | Thermal anneal of block copolymer films with top interface constrained to wet both blocks with equal preference |
US8425982B2 (en) | 2008-03-21 | 2013-04-23 | Micron Technology, Inc. | Methods of improving long range order in self-assembly of block copolymer films with ionic liquids |
EP2265430B1 (en) * | 2008-04-02 | 2011-10-12 | Novartis AG | Method and system for making ophthalmic devices using stereolithography and a single moulding surface |
US8114300B2 (en) | 2008-04-21 | 2012-02-14 | Micron Technology, Inc. | Multi-layer method for formation of registered arrays of cylindrical pores in polymer films |
US8114301B2 (en) | 2008-05-02 | 2012-02-14 | Micron Technology, Inc. | Graphoepitaxial self-assembly of arrays of downward facing half-cylinders |
CA2730506A1 (en) | 2008-07-21 | 2010-01-28 | Novartis Ag | Silicone-containing polymeric materials with hydrolyzable groups |
EP2174586B1 (en) | 2008-10-02 | 2014-12-10 | EyeSense AG | Implantable sensor element |
CN102300560B (en) | 2008-12-02 | 2016-09-07 | 生物相容英国有限公司 | Pancreas tumor is treated |
TWI506333B (en) * | 2008-12-05 | 2015-11-01 | Novartis Ag | Ophthalmic devices for delivery of hydrophobic comfort agents and preparation method thereof |
EP2373479B1 (en) * | 2008-12-18 | 2018-05-16 | Novartis AG | Mold and method for manufacturing an ophtalmic lens |
WO2010071691A1 (en) | 2008-12-18 | 2010-06-24 | Novartis Ag | Method for making silicone hydrogel contact lenses |
US20100155972A1 (en) * | 2008-12-18 | 2010-06-24 | Tollefson Norris M | Injection molded ophthalmic lens mold |
BRPI0823397A2 (en) | 2008-12-29 | 2015-06-16 | Synthes Gmbh | Method for forming a membrane composition to preserve a surgical site and the membrane composition itself |
RU2544540C2 (en) | 2008-12-30 | 2015-03-20 | Новартис Аг | Trifunctional compounds absorbing uv-radiation and application thereof |
HUE027398T2 (en) | 2009-05-22 | 2016-10-28 | Novartis Ag | Actinically-crosslinkable siloxane-containing copolymers |
WO2010135481A1 (en) | 2009-05-22 | 2010-11-25 | Novartis Ag | Actinically-crosslinkable siloxane-containing copolymers |
US8258200B2 (en) * | 2009-06-02 | 2012-09-04 | The University Of Akron | Polymer networks, process for producing same, and products made therefrom |
MX2012003140A (en) | 2009-09-15 | 2012-04-20 | Novartis Ag | Prepolymers suitable for making ultra-violet absorbing contact lenses. |
CN102648083B (en) * | 2009-11-04 | 2015-06-17 | 诺华股份有限公司 | Method for making a colored contact lens |
CN102639636A (en) * | 2009-12-07 | 2012-08-15 | 诺瓦提斯公司 | Methods for increasing the ion permeability of contact lenses |
TWI483996B (en) * | 2009-12-08 | 2015-05-11 | Novartis Ag | A silicone hydrogel lens with a covalently attached coating |
WO2011075377A1 (en) * | 2009-12-14 | 2011-06-23 | Novartis Ag | Methods for making silicone hydrogel lenses from water-based lens formulations |
SG181434A1 (en) * | 2009-12-17 | 2012-07-30 | Novartis Ag | Pad transfer printing method for making colored contact lenses |
JP5618053B2 (en) * | 2010-03-24 | 2014-11-05 | 株式会社日本コンタクトレンズ | Contact lens and manufacturing method thereof |
US9232805B2 (en) | 2010-06-29 | 2016-01-12 | Biocure, Inc. | In-situ forming hydrogel wound dressings containing antimicrobial agents |
SG187129A1 (en) | 2010-07-29 | 2013-02-28 | Novartis Ag | Colored contact lenses and method of making the same |
RU2569365C2 (en) | 2010-07-30 | 2015-11-27 | Новартис Аг | Method of making uv-absorbing ophthalmic lenses |
RU2540655C2 (en) | 2010-07-30 | 2015-02-10 | Новартис Аг | Silicone hydrogel lenses with water-rich surfaces |
NZ604337A (en) | 2010-07-30 | 2014-05-30 | Novartis Ag | Amphiphilic polysiloxane prepolymers and uses thereof |
US8304493B2 (en) | 2010-08-20 | 2012-11-06 | Micron Technology, Inc. | Methods of forming block copolymers |
NZ606787A (en) | 2010-10-06 | 2014-11-28 | Novartis Ag | Water-processable silicone-containing prepolymers and uses thereof |
WO2012047964A1 (en) | 2010-10-06 | 2012-04-12 | Novartis Ag | Chain-extended polysiloxane crosslinkers with dangling hydrophilic polymer chains |
JP5784131B2 (en) | 2010-10-06 | 2015-09-24 | ノバルティス アーゲー | Polymerizable chain-extended polysiloxane with pendant hydrophilic groups |
US9623614B2 (en) | 2010-11-10 | 2017-04-18 | Novartis Ag | Method for making contact lenses |
EP2646228B1 (en) | 2010-12-01 | 2014-09-17 | Novartis AG | Method for producing ophthalmic lenses |
WO2012078457A1 (en) | 2010-12-06 | 2012-06-14 | Novartis Ag | Method for making silicone hydrogel contact lenses |
HUE030629T2 (en) | 2010-12-13 | 2017-05-29 | Novartis Ag | Ophthalmic lenses modified with functional groups and methods of making thereof |
KR20130128431A (en) | 2010-12-14 | 2013-11-26 | 노파르티스 아게 | Colored contact lens |
EP2757964B1 (en) | 2011-05-26 | 2016-05-04 | Cartiva, Inc. | Tapered joint implant and related tools |
KR101318211B1 (en) | 2011-05-31 | 2013-10-15 | 한국기계연구원 | Active compensated stage having 5-dof motion error compensation and motion error compensating method thereof |
TWI551646B (en) * | 2011-06-03 | 2016-10-01 | 諾華公司 | Hydrophobic acrylic intraocular lens materials |
CA2838242C (en) | 2011-06-09 | 2016-05-17 | Novartis Ag | Silicone hydrogel lenses with nano-textured surfaces |
EP2742510A1 (en) | 2011-08-11 | 2014-06-18 | Cellular Bioengineering, Inc. | Polymer composition |
HUE029018T2 (en) | 2011-10-12 | 2017-02-28 | Novartis Ag | Method for making uv-absorbing ophthalmic lenses by coating |
US8900963B2 (en) | 2011-11-02 | 2014-12-02 | Micron Technology, Inc. | Methods of forming semiconductor device structures, and related structures |
JP6072060B2 (en) | 2011-11-15 | 2017-02-01 | ノバルティス アーゲー | Silicone hydrogel lens with cross-linked hydrophilic coating |
CN103958167B (en) | 2011-11-29 | 2017-03-08 | 诺华股份有限公司 | For moulding the processing method of the lens forming surface of at least one half module of the mould of eye-use lens |
CA2857181C (en) | 2011-12-08 | 2016-10-11 | Novartis Ag | Contact lenses with enzymatically degradable coatings thereon |
US9283718B2 (en) | 2012-05-25 | 2016-03-15 | Johnson & Johnson Vision Care, Inc. | Reduced-tilt back plastic feature for a contact lens mold |
KR102051174B1 (en) | 2012-06-14 | 2019-12-02 | 노파르티스 아게 | Azetidinium-containing copolymers and uses thereof |
US9395468B2 (en) | 2012-08-27 | 2016-07-19 | Ocular Dynamics, Llc | Contact lens with a hydrophilic layer |
US9087699B2 (en) | 2012-10-05 | 2015-07-21 | Micron Technology, Inc. | Methods of forming an array of openings in a substrate, and related methods of forming a semiconductor device structure |
WO2014093764A1 (en) | 2012-12-14 | 2014-06-19 | Novartis Ag | Amphiphilic siloxane-containing (meth)acrylamides and uses thereof |
JP6034982B2 (en) | 2012-12-14 | 2016-11-30 | ノバルティス アーゲー | Actinic crosslinkable amphiphilic prepolymer |
US9103965B2 (en) | 2012-12-14 | 2015-08-11 | Novartis Ag | Amphiphilic siloxane-containing vinylic monomers and uses thereof |
EP2931733B1 (en) | 2012-12-14 | 2016-10-05 | Novartis AG | Tris(trimethyl siloxy)silane vinylic monomers and uses thereof |
US10338408B2 (en) | 2012-12-17 | 2019-07-02 | Novartis Ag | Method for making improved UV-absorbing ophthalmic lenses |
JP6420817B2 (en) * | 2013-03-15 | 2018-11-07 | バイオコンパティブルズ ユーケー リミテッド | Imageable embolic microspheres |
US9229328B2 (en) | 2013-05-02 | 2016-01-05 | Micron Technology, Inc. | Methods of forming semiconductor device structures, and related semiconductor device structures |
US9950483B2 (en) | 2013-05-29 | 2018-04-24 | Novartis Ag | Method for determining the surface concentration of carboxyl groups on a lens |
US9693833B2 (en) | 2013-08-05 | 2017-07-04 | Merit Medical Systems, Inc. | Absorbent cleaning and securement devices and methods |
GB2519738A (en) | 2013-09-06 | 2015-05-06 | Biocompatibles Uk Ltd | Radiopaque polymers |
GB2521997A (en) | 2013-09-06 | 2015-07-15 | Biocompatibles Uk Ltd | Radiopaque polymers |
US9177795B2 (en) | 2013-09-27 | 2015-11-03 | Micron Technology, Inc. | Methods of forming nanostructures including metal oxides |
US9568645B2 (en) | 2013-09-30 | 2017-02-14 | Novartis Ag | Silicone hydrogel lenses with relatively-long thermal stability |
WO2015048035A1 (en) | 2013-09-30 | 2015-04-02 | Novartis Ag | Method for making uv-absorbing ophthalmic lenses |
US9765166B2 (en) | 2013-10-17 | 2017-09-19 | The Nippon Synthetic Chemical Industry Co., Ltd. | Crosslinkable polymer |
MY175124A (en) | 2013-10-31 | 2020-06-09 | Alcon Inc | Method for producing ophthalmic lenses |
TWI654440B (en) | 2013-11-15 | 2019-03-21 | 美商實體科學公司 | Contact lens with hydrophilic layer |
EP3079888B1 (en) | 2013-12-13 | 2018-01-31 | Novartis AG | Method for making contact lenses |
SG11201603699SA (en) | 2013-12-17 | 2016-07-28 | Novartis Ag | A silicone hydrogel lens with a crosslinked hydrophilic coating |
SG11201603722SA (en) | 2013-12-20 | 2016-07-28 | Novartis Ag | Reusable castings molds and method of making such molds |
MY177298A (en) | 2013-12-20 | 2020-09-11 | Alcon Inc | Molds for making contact lenses |
WO2015134449A1 (en) | 2014-03-05 | 2015-09-11 | Novartis Ag | Method for automatic inspection of contact lenses |
US9618773B2 (en) | 2014-04-08 | 2017-04-11 | Novartis Ag | Ophthalmic lenses with oxygen-generating elements therein |
EP3134461B1 (en) | 2014-04-25 | 2018-02-14 | Novartis AG | Hydrophilized carbosiloxane vinylic monomers |
CA2940203C (en) | 2014-04-25 | 2019-08-06 | Novartis Ag | Carbosiloxane vinylic monomers |
BR112017003447B1 (en) | 2014-08-26 | 2021-10-26 | Alcon Inc | POLY(OXAZOLINE-CO-ETHYLENEIMIN)-EPICHLORIDRINE COPOLYMER, HYDROPHILIC THERMALLY CROSS-CULTURE AND WATER SOLUBLE POLYMER MATERIAL, AND METHODS FOR PRODUCING COATED CONTACT LENSES |
SG11201700232SA (en) | 2014-08-26 | 2017-03-30 | Novartis Ag | Method for applying stable coating on silicone hydrogel contact lenses |
US9555151B2 (en) | 2014-10-03 | 2017-01-31 | Soft Health Technologies, Llc | Systems and methods for incontinence control |
US10160141B2 (en) | 2014-11-25 | 2018-12-25 | Novartis Ag | Molds for making contact lenses |
AU2015360637B2 (en) | 2014-12-09 | 2019-08-22 | Tangible Science, Inc. | Medical device coating with a biocompatible layer |
HUE044106T2 (en) | 2014-12-17 | 2019-09-30 | Novartis Ag | Reusable lens molds and methods of use thereof |
WO2016100457A1 (en) | 2014-12-17 | 2016-06-23 | Novartis Ag | Reusable lens molds and methods of use thereof |
WO2016100450A1 (en) | 2014-12-17 | 2016-06-23 | Novartis Ag | Reusable lens molds and methods of use thereof |
US9976112B2 (en) | 2015-03-04 | 2018-05-22 | Merit Medical Systems, Inc. | Absorbent pads and methods of manufacturing |
WO2016145204A1 (en) | 2015-03-11 | 2016-09-15 | University Of Florida Research Foundation, Inc. | Mesh size control of lubrication in gemini hydrogels |
AU2016243660B2 (en) | 2015-03-31 | 2020-11-12 | Cartiva, Inc. | Carpometacarpal (CMC) implants and methods |
WO2016161025A1 (en) | 2015-03-31 | 2016-10-06 | Cartiva, Inc. | Hydrogel implants with porous materials and methods |
AU2016248062B2 (en) | 2015-04-14 | 2020-01-23 | Cartiva, Inc. | Tooling for creating tapered opening in tissue and related methods |
MX370083B (en) | 2015-05-06 | 2019-11-29 | Zoetis Services Llc | Hydrogel formulation with mild adhesion. |
EP3291976B1 (en) | 2015-05-07 | 2020-01-15 | Novartis AG | Method for producing contact lenses with durable lubricious coatings thereon |
CA2982707C (en) | 2015-06-02 | 2019-11-12 | Novartis Ag | Visible-light photoinitiators and uses thereof |
GB201515602D0 (en) | 2015-09-03 | 2015-10-21 | Biocompatibles Uk Ltd | Polymers and microspheres |
WO2017037610A1 (en) | 2015-09-04 | 2017-03-09 | Novartis Ag | Method for producing contact lenses with durable lubricious coatings thereon |
US10322993B2 (en) | 2015-12-02 | 2019-06-18 | Novartis Ag | Water-soluble UV-absorbing compounds and uses thereof |
CA3002506C (en) | 2015-12-03 | 2020-07-14 | Novartis Ag | Contact lens packaging solutions |
CN108369291B (en) | 2015-12-15 | 2021-07-20 | 爱尔康公司 | Method for applying a stable coating on a silicone hydrogel contact lens |
EP3390026A1 (en) | 2015-12-15 | 2018-10-24 | Novartis AG | Method for producing contact lenses with a lubricious surface |
JP6615349B2 (en) | 2015-12-15 | 2019-12-04 | ノバルティス アーゲー | Amphiphilic branched polydiorganosiloxane macromer |
SG11201803723QA (en) | 2015-12-17 | 2018-07-30 | Novartis Ag | Reusable lens molds and methods of use thereof |
EP3419961B1 (en) | 2016-02-22 | 2020-09-02 | Alcon Inc. | Uv/visible-absorbing vinylic monomers and uses thereof |
CA3010331C (en) | 2016-02-22 | 2021-06-22 | Novartis Ag | Uv-absorbing vinylic monomers and uses thereof |
EP3516429B1 (en) | 2016-09-20 | 2021-02-17 | Alcon Inc. | Colored hydrogel contact lenses with lubricious coating thereon |
CA3032588C (en) | 2016-09-20 | 2021-03-23 | Novartis Ag | Hydrogel contact lenses with lubricious coating thereon |
US10526470B2 (en) | 2016-09-20 | 2020-01-07 | Novartis Ag | Method for producing a water-soluble thermally-crosslinkable polymeric material |
WO2018055491A1 (en) | 2016-09-20 | 2018-03-29 | Novartis Ag | Process for producing contact lenses with durable lubricious coatings thereon |
JP6777814B2 (en) | 2016-10-19 | 2020-10-28 | アルコン インク. | Hydrophilic copolymer with one thiol-containing end group |
CA3104325C (en) | 2016-10-19 | 2023-01-24 | Alcon Inc. | Hydrophilic copolymer with pendant thiol groups |
CN109844570A (en) | 2016-10-26 | 2019-06-04 | 诺华股份有限公司 | There are the soft contact lenses for the lubricant coating being covalently attached on it |
EP3532519A1 (en) | 2016-10-26 | 2019-09-04 | Novartis AG | Amphiphilic branched polydiorganosiloxane macromers |
EP3532276B1 (en) | 2016-10-31 | 2021-03-03 | Alcon Inc. | Method for producing surface coated contact lenses with wearing comfort |
US20180141293A1 (en) | 2016-11-18 | 2018-05-24 | Novartis Ag | Method for making ophthalmic lenses |
US10156736B2 (en) | 2017-04-13 | 2018-12-18 | Novartis Ag | Colored contact lenses and method of making the same |
JP6898466B2 (en) | 2017-04-13 | 2021-07-07 | アルコン インク. | Color contact lenses and their manufacturing methods |
EP3655446B1 (en) | 2017-07-18 | 2022-08-31 | Alcon Inc. | Water-soluble, thermally-crosslinkable polymeric material comprising one or more poly(meth)acrylamide-based copolymers with carboxyl-terminated pendant chains |
WO2019016695A1 (en) | 2017-07-18 | 2019-01-24 | Novartis Ag | Phosphorylcholine-containing poly(meth)acrylamide-based copolymers |
JP6423495B1 (en) | 2017-07-21 | 2018-11-14 | 株式会社メンテック | NOZZLE CAP, NOZZLE DEVICE PROVIDED WITH THE SAME |
US10809181B2 (en) | 2017-08-24 | 2020-10-20 | Alcon Inc. | Method and apparatus for determining a coefficient of friction at a test site on a surface of a contact lens |
EP3676082A1 (en) | 2017-08-29 | 2020-07-08 | Alcon Inc. | Cast-molding process for producing contact lenses |
CN111386478B (en) | 2017-12-13 | 2023-11-14 | 爱尔康公司 | Zhou Pao and month polishing gradient contact lens |
US11111327B2 (en) | 2018-01-22 | 2021-09-07 | Alcon Inc. | Cast-molding process for producing UV-absorbing contact lenses |
US10962803B2 (en) | 2018-01-30 | 2021-03-30 | Alcon Inc. | Contact lenses with a lubricious coating thereon |
JP6842435B2 (en) | 2018-02-19 | 2021-03-17 | 信越化学工業株式会社 | Radical curable organosiloxane graft polyvinyl alcohol polymer and its production method |
US11448796B2 (en) | 2018-04-13 | 2022-09-20 | Alcon Inc. | Evaluation method for the coverage of a coating on a contact lens surface |
US11702498B2 (en) | 2018-06-29 | 2023-07-18 | Biocompatibles Uk Limited | Radiopaque polymers |
US11061169B2 (en) | 2018-11-15 | 2021-07-13 | Alcon Inc. | Contact lens with phosphorylcholine-modified polyvinylalcohols therein |
SG11202105510TA (en) | 2019-01-28 | 2021-08-30 | Alcon Inc | High molecular weight poly(methacrylic acid) |
US20200297635A1 (en) | 2019-03-22 | 2020-09-24 | Biocompatibles Uk Limited | Embolic microspheres and methods |
US11648583B2 (en) | 2019-04-10 | 2023-05-16 | Alcon Inc. | Method for producing coated contact lenses |
EP3976381A1 (en) | 2019-05-28 | 2022-04-06 | Alcon Inc. | Pad transfer printing instrument and method for making colored contact lenses |
US20210132411A1 (en) | 2019-11-04 | 2021-05-06 | Alcon Inc. | Contact lenses with surfaces having different softness |
WO2021090170A1 (en) | 2019-11-05 | 2021-05-14 | Alcon Inc. | Method for determining coating thickness on coated contact lenses |
CN114981072B (en) | 2019-12-16 | 2024-03-26 | 爱尔康公司 | Wettable silicone hydrogel contact lenses |
US20210271109A1 (en) | 2019-12-19 | 2021-09-02 | Alcon Inc. | Cosmetic contact lens for color blindness |
US20210284778A1 (en) | 2020-03-11 | 2021-09-16 | Alcon Inc. | Photochromic polydiorganosiloxane vinylic crosslinkers |
TWI803920B (en) | 2020-07-28 | 2023-06-01 | 瑞士商愛爾康公司 | Coated contact lens and method for making the same |
US20220134692A1 (en) | 2020-11-04 | 2022-05-05 | Alcon Inc. | Method for making photochromic contact lenses |
EP4240578A1 (en) | 2020-11-04 | 2023-09-13 | Alcon Inc. | Method for making photochromic contact lenses |
JP2024505928A (en) | 2021-02-09 | 2024-02-08 | アルコン インク. | Hydrophilized polydiorganosiloxane vinyl crosslinker |
KR20230131494A (en) | 2021-03-08 | 2023-09-13 | 알콘 인코포레이티드 | Method for manufacturing photofunctional contact lenses |
TWI826948B (en) | 2021-03-11 | 2023-12-21 | 瑞士商愛爾康公司 | Colored hydrogel contact lens and method for producing the same |
JP2024508842A (en) | 2021-03-23 | 2024-02-28 | アルコン インク. | High refractive index polysiloxane vinyl crosslinker |
KR20230132841A (en) | 2021-03-24 | 2023-09-18 | 알콘 인코포레이티드 | Method for manufacturing intraocular hydrogel contact lenses |
KR20230144635A (en) | 2021-04-01 | 2023-10-16 | 알콘 인코포레이티드 | Method for manufacturing embedded hydrogel contact lenses |
WO2022208447A1 (en) | 2021-04-01 | 2022-10-06 | Alcon Inc. | Embedded hydrogel contact lenses |
WO2022224169A1 (en) | 2021-04-22 | 2022-10-27 | Alcon Inc. | Method for applying a coating onto a non-silicone hydrogel lens |
JP2024513014A (en) | 2021-04-29 | 2024-03-21 | アルコン インク. | Color cosmetic photochromic contact lenses |
CN117280252A (en) | 2021-06-14 | 2023-12-22 | 爱尔康公司 | Multifocal diffractive silicone hydrogel contact lenses |
US20230201122A1 (en) | 2021-12-23 | 2023-06-29 | Boston Scientific Medical Device Limited | Chemoembolic compositions and methods of treatment using them |
US20230339149A1 (en) | 2022-04-26 | 2023-10-26 | Alcon Inc. | Method for making embedded hydrogel contact lenses |
US20230339148A1 (en) | 2022-04-26 | 2023-10-26 | Alcon Inc. | Method for making embedded hydrogel contact lenses |
WO2023209631A1 (en) | 2022-04-28 | 2023-11-02 | Alcon Inc. | Method for making uv and hevl-absorbing ophthalmic lenses |
TW202402514A (en) | 2022-05-09 | 2024-01-16 | 瑞士商愛爾康公司 | Method for making embedded hydrogel contact lenses |
US20230374306A1 (en) | 2022-05-23 | 2023-11-23 | Alcon Inc. | Uv/hevl-filtering contact lenses |
US20230382065A1 (en) | 2022-05-25 | 2023-11-30 | Alcon Inc. | Method for making embedded hydrogel contact lenses |
US20240092043A1 (en) | 2022-08-17 | 2024-03-21 | Alcon Inc. | Contact lens with a hydrogel coating thereon |
Family Cites Families (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1495381B2 (en) * | 1963-09-07 | 1971-06-24 | Czeskoslovenska akademie ved , Prag | METHOD FOR MANUFACTURING CONTACT LENSES OR CONTACT LENS BLOCKS FROM SWELLABLE HYDROGELS |
NL128305C (en) | 1963-09-11 | |||
JPS501246A (en) * | 1973-05-11 | 1975-01-08 | ||
JPS50124608A (en) * | 1974-03-18 | 1975-09-30 | ||
US4113224A (en) * | 1975-04-08 | 1978-09-12 | Bausch & Lomb Incorporated | Apparatus for forming optical lenses |
SU558248A1 (en) * | 1974-12-17 | 1977-05-15 | Московский научно-исследовательский институт глазных болезней им. Гельмгольца | Combined contact lens and method of its manufacture |
JPS5247883A (en) * | 1975-10-16 | 1977-04-16 | Kansai Paint Co Ltd | Preparation of molded product of hydrogel |
JPS52124608A (en) * | 1976-04-10 | 1977-10-19 | Daido Shingo | Method of controlling train |
DE2839249A1 (en) | 1977-09-12 | 1979-03-22 | Toray Industries | METHOD OF MANUFACTURING A SOFT CONTACT LENS AND OUTPUT SOLUTION FOR CARRYING OUT THE METHOD |
EP0017512B1 (en) | 1979-04-10 | 1984-11-14 | Kelvin Lenses Limited | Polymeric materials, process for preparing them and shaped articles and contact lenses formed from them |
DE3113690A1 (en) * | 1981-04-04 | 1982-10-28 | Elastogran GmbH, 2844 Lemförde | "METHOD FOR PRODUCING CLOSED-CELL POLYURETHANE MOLDED PARTS WITH A COMPRESSED EDGE ZONE" |
US4426492A (en) * | 1981-09-03 | 1984-01-17 | Plastomedical Sciences, Inc. | Disposable, hydrogel soft contact lenses |
JPH0234994B2 (en) * | 1981-09-21 | 1990-08-07 | Sunstar Engineering Inc | TAKOSHITSUZAINOSEKISOSEIKEIKAKOHO |
US4430458A (en) * | 1981-10-08 | 1984-02-07 | Kelvin Lenses Limited | Hydrogel-forming polymeric materials |
JPS58104286A (en) * | 1981-12-16 | 1983-06-21 | ジェイエスアール株式会社 | Production of colored molded product |
GB2144749B (en) | 1983-08-09 | 1986-10-08 | Plastomedical Sciences Inc | Disposable, hydrogel soft cantact lenses |
CH664924A5 (en) * | 1984-12-04 | 1988-04-15 | Stella Werke Ag | METHOD FOR PRODUCING DUROPLASTIC SHEET PANELS AND DEVICE FOR IMPLEMENTING THE METHOD. |
US4598122A (en) * | 1985-01-22 | 1986-07-01 | Ciba-Geigy Corporation | Polyoxirane crosslinked polyvinyl alcohol hydrogel contact lens |
CA1283907C (en) | 1985-03-21 | 1991-05-07 | Robert K. Pinschmidt, Jr. | Self-and diol reactive formaldehyde-free crosslinking monomers and their derived polymers |
US4864055A (en) * | 1985-03-21 | 1989-09-05 | Air Products And Chemicals, Inc. | Self- and diol reactive formaldehyde-free crosslinking monomers and their derived polymers |
US4691026A (en) * | 1985-07-30 | 1987-09-01 | Air Products And Chemicals, Inc. | Self- and hydroxyl reactive formaldehyde-free cyclic hemiamidal and hemiamide ketal crosslinking monomers |
US4788288A (en) * | 1985-07-30 | 1988-11-29 | Air Products And Chemicals, Inc. | Self-and Hydroxyl reactive formaldehyde-free cyclic hemiamidal and hemiamide ketal crosslinking monomers |
EP0216074B1 (en) * | 1985-07-31 | 1993-06-16 | Ciba-Geigy Ag | Polyvinyl alcohol derivatives and crosslinked hydrogel contact lenses made therefrom |
US4665123A (en) * | 1985-12-13 | 1987-05-12 | Ciba-Geigy Corporation | Polyvinyl alcohol derivatives containing pendant (meth)acryloylvinylic monomer reaction product units bound through urethane groups and hydrogel contact lenses made therefrom |
US4663410A (en) * | 1985-08-06 | 1987-05-05 | Air Products And Chemicals, Inc. | Polymers of self- and hydroxyl reactive formaldehyde-free cyclic hemiamidal and hemiamide ketal crosslinking monomers |
US4670506A (en) * | 1985-12-23 | 1987-06-02 | Ciba-Geigy Corporation | Polyvinyl alcohol derivatives containing pendant (meth)acryloyl units bound through urethane groups and crosslinked hydrogel contact lenses made therefrom |
JPH07100777B2 (en) * | 1986-01-10 | 1995-11-01 | 大日本インキ化学工業株式会社 | Light or electron beam cross-linking type water-based coating agent |
JPS6334108A (en) * | 1986-07-30 | 1988-02-13 | Hitachi Ltd | Manufacture of substrate for optical disc and device therefor |
JPH0762048B2 (en) * | 1986-09-25 | 1995-07-05 | 工業技術院長 | Photosensitive resin |
US4904421A (en) * | 1987-11-25 | 1990-02-27 | Tomei Sangyo Kabushiki Kaisha | Soft ocular lens and method for its preparation |
US4978713A (en) * | 1987-12-16 | 1990-12-18 | Ciba-Geigy Corporation | Polyvinyl alcohol derivatives containing pendant vinylic monomer reaction product units bound through ether groups and hydrogel contact lenses made therefrom |
JPH02109792A (en) * | 1988-10-20 | 1990-04-23 | Ishikawajima Harima Heavy Ind Co Ltd | Liquefied gas transport ship |
JPH07108627B2 (en) * | 1988-10-20 | 1995-11-22 | 株式会社クボタ | Accelerator device for work vehicle |
JP2860388B2 (en) * | 1990-01-19 | 1999-02-24 | 工業技術院長 | Materials for intraocular lenses |
JPH047302A (en) * | 1990-04-25 | 1992-01-10 | Japan Synthetic Rubber Co Ltd | Preparation of gel |
JPH04109792A (en) * | 1990-08-29 | 1992-04-10 | Sharp Corp | Automatic sales data collection system |
DE69113392T2 (en) * | 1990-10-30 | 1996-05-15 | Minnesota Mining & Mfg | Procedures for networking conspicuous objects. |
GB2263699B (en) * | 1992-02-03 | 1995-11-29 | Sericol Ltd | Photopolymerizable alcohols and compositions containing them |
US5360864A (en) * | 1992-05-04 | 1994-11-01 | Ulano Corporation | Process for preparation of photosensitive composition |
US5326669A (en) * | 1992-05-04 | 1994-07-05 | Ulano Corporation | Photosensitive compositions |
-
1993
- 1993-10-27 TW TW082108941A patent/TW272976B/zh not_active IP Right Cessation
-
1994
- 1994-07-26 EP EP94810444A patent/EP0641806B1/en not_active Expired - Lifetime
- 1994-07-26 PT PT97103579T patent/PT790258E/en unknown
- 1994-07-26 DE DE59405162T patent/DE59405162D1/en not_active Expired - Lifetime
- 1994-07-26 ES ES97103579T patent/ES2208779T3/en not_active Expired - Lifetime
- 1994-07-26 AT AT97103579T patent/ATE251183T1/en active
- 1994-07-26 ES ES94810444T patent/ES2112503T3/en not_active Expired - Lifetime
- 1994-07-26 DE DE59410329T patent/DE59410329D1/en not_active Expired - Lifetime
- 1994-07-26 DK DK94810444T patent/DK0641806T3/en active
- 1994-07-26 AT AT94810444T patent/ATE162814T1/en active
- 1994-07-26 EP EP97103579A patent/EP0790258B1/en not_active Expired - Lifetime
- 1994-07-26 SG SG9601209A patent/SG49623A1/en unknown
- 1994-07-26 DK DK97103579T patent/DK0790258T3/en active
- 1994-07-28 IL IL11048794A patent/IL110487A/en not_active IP Right Cessation
- 1994-07-28 IL IL12319294A patent/IL123192A/en not_active IP Right Cessation
- 1994-07-29 AU AU68802/94A patent/AU680507B2/en not_active Expired
- 1994-08-03 CZ CZ19941869A patent/CZ289627B6/en not_active IP Right Cessation
- 1994-08-03 FI FI943614A patent/FI114714B/en not_active IP Right Cessation
- 1994-08-04 HU HU0002451A patent/HU228123B1/en unknown
- 1994-08-04 NZ NZ286397A patent/NZ286397A/en not_active IP Right Cessation
- 1994-08-04 JP JP6183535A patent/JP2914872B2/en not_active Expired - Lifetime
- 1994-08-04 CA CA002129461A patent/CA2129461C/en not_active Expired - Lifetime
- 1994-08-04 NZ NZ264175A patent/NZ264175A/en not_active IP Right Cessation
- 1994-08-04 US US08/286,035 patent/US5508317A/en not_active Expired - Lifetime
- 1994-08-04 CA CA002221162A patent/CA2221162C/en not_active Expired - Lifetime
- 1994-08-04 HU HU9402297A patent/HU221056B1/en unknown
- 1994-08-05 PL PL94304580A patent/PL178192B1/en unknown
- 1994-08-05 ZA ZA945872A patent/ZA945872B/en unknown
- 1994-08-05 NO NO942908A patent/NO942908D0/no unknown
- 1994-08-05 BR BR9403174A patent/BR9403174A/en not_active IP Right Cessation
- 1994-08-05 RU RU94028652A patent/RU2141896C1/en active
- 1994-08-05 NO NO942907A patent/NO309381B1/en not_active IP Right Cessation
- 1994-08-05 CN CN94115001A patent/CN1062513C/en not_active Expired - Lifetime
- 1994-08-05 KR KR1019940019316A patent/KR100336138B1/en not_active IP Right Cessation
-
1995
- 1995-06-05 US US08/463,546 patent/US5583163A/en not_active Expired - Lifetime
- 1995-12-22 US US08/575,799 patent/US5789464A/en not_active Expired - Lifetime
-
1996
- 1996-07-03 US US08/678,437 patent/US5849810A/en not_active Expired - Lifetime
-
1997
- 1997-05-22 AU AU23579/97A patent/AU705891B2/en not_active Expired
- 1997-09-11 NO NO19974192A patent/NO318658B1/en not_active IP Right Cessation
-
1998
- 1998-02-05 IL IL12319298A patent/IL123192A0/en unknown
- 1998-02-11 GR GR980400267T patent/GR3026098T3/en unknown
- 1998-05-23 HK HK98104469A patent/HK1005338A1/en not_active IP Right Cessation
-
2001
- 2001-06-22 CZ CZ20012351A patent/CZ291162B6/en not_active IP Right Cessation
-
2003
- 2003-03-31 FI FI20030475A patent/FI114713B/en not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2221162C (en) | Photocrosslinked polymers and prepolymers thereof | |
EP0807269B1 (en) | Crosslinkable polymers containing photoinitiators | |
AU698876B2 (en) | Crosslinked polymers containing salt structures | |
US6149842A (en) | Methods and compositions for manufacturing tinted ophthalmic lenses | |
KR20000029695A (en) | Method and composition for incorporating radiation-absorbing agents into polymers | |
US6407145B1 (en) | Photocrosslinkable materials and applications | |
US6149692A (en) | Method and composition for incorporating radiation-absorbing agents into polymers | |
EP1029250B1 (en) | Methods and compositions for manufacturing tinted ophthalmic lenses | |
EP0951654B1 (en) | Manufacture of mouldings | |
AU734885B2 (en) | Method and composition for incorporating radiation-absorbing agents into polymers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |
Effective date: 20140804 |